This is a non-core endpoint: only basic statistics are computed.
See these related core endpoints for full statistics:
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
1 out of 7 registries used, show all original rules. |
5246 |
4. Check minimum number of eventsNone |
5246 |
5. Include endpointsNone |
5246 |
6. Filter based on genotype QC (FinnGen only) |
5246 |
Control definitions (FinnGen only)
- Control exclude
- ASTHMA_NOS
Extra metadata
- First used in FinnGen datafreeze
- DF2
FESS (DNB20)
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
This endpoint is excluded from FinRegistry analyses (omitted endpoint).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 5246 | 2908 | 2338 |
| Unadjusted period prevalence (%) | 1.01 | 0.99 | 1.03 |
| Median age at first event (years) | 48.79 | 46.49 | 51.65 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
Not a core endpoint, no data to show.
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 4756
- Matched controls
- 47558
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
J01.0
ICD-10 Finland
Acute maxillary sinusitis
6.2
323.0
2327
6361
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
5.3
323.0
1768
4786
J32.2
ICD-10 Finland
Chronic ethmoidal sinusitis
229.4
323.0
786
41
DNB20
NOMESCO Finland
Endoscopic ethmoidectomy
+∞
323.0
4756
*
DMB20
NOMESCO Finland
Functional endoscopic opening of maxillary antrum
179.2
323.0
3514
738
J01AA02
ATC
doxycycline; systemic
4.9
323.0
4269
30593
J33.0
ICD-10 Finland
Polyp of nasal cavity
52.5
323.0
1311
342
UDM02
NOMESCO Finland
Sinoscopy
56.2
323.0
1118
258
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
4.6
323.0
3547
18471
DHB20
NOMESCO Finland
Polypectomy of internal nose
52.0
323.0
664
148
J32.0
ICD-10 Finland
Chronic maxillary sinusitis
60.6
323.0
3014
1318
J45.9
ICD-10 Finland
Asthma, unspecified
5.3
323.0
1604
4134
ZXA10
NOMESCO Finland
Bilateral
4.7
323.0
1572
4513
J01FA10
ATC
azithromycin; systemic
3.8
323.0
3621
21681
J33.8
ICD-10 Finland
Other polyp of sinus
94.6
323.0
1333
195
DM1AD
NOMESCO Finland
CT of paranasal sinuses and face area
22.7
323.0
1071
602
R01AD12
ATC
fluticasone furoate; nasal
4.5
323.0
2561
9746
R01AD58
ATC
fluticasone, combinations; inhalant, nasal
4.6
323.0
1974
6313
DPA30
NOMESCO Finland
Sphenotomy
268.5
323.0
547
23
DPA25
NOMESCO Finland
Trephine of frontal sinus through nose
256.2
323.0
700
32
R03DC03
ATC
montelukast; oral
6.7
323.0
1861
4177
R01AD08
ATC
fluticasone; nasal
19.7
323.0
3887
8777
TDM10
NOMESCO Finland
Puncture of maxillary antrum
27.3
323.0
1228
598
R01AD09
ATC
mometasone; nasal
7.2
323.0
3712
15728
DM1AI
NOMESCO Finland
Cone beam CT of paranasal sinus
27.1
323.0
814
359
J34.2
ICD-10 Finland
Deviated nasal septum
8.2
323.0
822
1184
H02AB06
ATC
prednisolone; systemic
8.1
323.0
3766
15142
J32.4
ICD-10 Finland
Chronic pansinusitis
178.2
323.0
1221
92
R03AC02
ATC
salbutamol; inhalant
3.4
323.0
3238
18197
UDH02
NOMESCO Finland
Rhinopharyngoscopy
22.2
323.0
1800
1270
R01BA52
ATC
pseudoephedrine, combinations; oral
3.7
323.0
2374
10052
DHB50
NOMESCO Finland
Turbinoplasty
13.8
322.4
579
472
H02AB04
ATC
methylprednisolone; systemic
4.5
312.5
1305
3667
J01FA09
ATC
clarithromycin; systemic
3.3
305.3
2266
10296
DJD20
NOMESCO Finland
Plastic repair of septum of nose
9.6
302.9
659
785
R01AD05
ATC
budesonide; nasal
6.0
300.9
931
1867
R01AD01
ATC
beclometasone; nasal
4.0
287.2
1387
4418
R03BA05
ATC
fluticasone; inhalant
3.8
279.4
1435
4806
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
5.0
255.1
928
2210
J33.9
ICD-10 Finland
Nasal polyp, unspecified
36.0
254.7
332
99
J31.0
ICD-10 Finland
Chronic rhinitis
5.5
253.2
826
1738
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
3.1
247.7
1793
7688
R03AK06
ATC
salmeterol and fluticasone; inhalant
4.2
244.0
1087
3156
R03AK07
ATC
formoterol and budesonide; inhalant
3.4
239.6
1465
5530
J45.0
ICD-10 Finland
Predominantly allergic asthma
4.9
224.7
812
1899
J32.1
ICD-10 Finland
Chronic frontal sinusitis
60.7
224.3
264
46
R01AD11
ATC
triamcinolone; nasal
4.6
221.7
875
2240
J45
ICD-10 Finland
Asthma
4.7
219.8
845
2105
ZXC95
NOMESCO Finland
Use of surgical navigator
21.5
216.1
325
162
J45.1
ICD-10 Finland
Nonallergic asthma
5.6
212.2
682
1391
J32.9
ICD-10 Finland
Chronic sinusitis, unspecified
25.7
207.5
295
122
J01CA04
ATC
amoxicillin; systemic
3.3
198.3
4180
32567
J01FA15
ATC
telithromycin; oral
3.9
191.3
897
2667
H02AB07
ATC
prednisone; oral
3.5
191.0
1037
3483
J01.1
ICD-10 Finland
Acute frontal sinusitis
14.1
189.0
333
252
R06AX27
ATC
desloratadine; oral
2.7
187.2
1779
8698
R06AE07
ATC
cetirizine; oral
2.5
187.2
2533
15044
DM1AA
NOMESCO Finland
Paranasal sinuses X-ray examination without contrast
8.0
179.9
432
588
J34.1
ICD-10 Finland
Cyst and mucocele of nose and nasal sinus
14.7
174.2
301
217
R03BA02
ATC
budesonide; inhalant
3.1
173.1
1175
4607
R06AE09
ATC
levocetirizine; oral
3.2
170.0
1076
4011
TDW99
NOMESCO Finland
Other minor procedure in surgery of ear, nose and larynx
7.5
160.9
402
579
R96
ICPC
Asthma
4.1
148.4
649
1783
WX408
NOMESCO Finland
General anesthesy, balanced
2.4
148.0
1616
8274
R03AK08
ATC
formoterol and beclometasone; inhalant
6.4
145.6
406
680
DPW99
NOMESCO Finland
Other operation on frontal or sphenoidal sinus
133.4
145.1
155
12
J01DC02
ATC
cefuroxime; systemic
4.6
143.3
544
1303
R09
ICPC
Sinus symptom/complaint
4.0
142.1
631
1754
J32.8
ICD-10 Finland
Other chronic sinusitis
63.2
141.2
165
27
J01DB01
ATC
cefalexin; oral
2.7
140.4
4107
33324
UDC00
NOMESCO Finland
Ear microscopy
4.0
131.6
576
1574
XG474
NOMESCO Finland
Exhalation nntrogen oxide
7.4
130.7
327
469
R03BA01
ATC
beclometasone; inhalant
2.9
130.2
903
3511
R03BA08
ATC
ciclesonide; inhalant
3.7
130.1
637
1917
UDQ12
NOMESCO Finland
Flexible laryngoscopy
4.5
126.1
480
1147
4222
FHL
Endonasal etmoidectomy
26.7
124.9
175
68
J01.4
ICD-10 Finland
Acute pansinusitis
22.3
123.9
183
85
DPA20
NOMESCO Finland
Trephine of frontal sinus
123.4
122.7
132
11
R03AK10
ATC
vilanterol and fluticasone furoate; inhalant
5.6
120.9
378
727
DMB00
NOMESCO Finland
Endonasal trephine of maxillary antrum
21.7
120.8
180
86
DHB40
NOMESCO Finland
Conchotomy
70.9
120.2
138
20
Z01.5
ICD-10 Finland
Diagnostic skin and sensitization tests
3.3
118.9
685
2330
J01DA06
ATC
[U] cefuroxime; systemic
2.7
117.0
945
4010
J01FA06
ATC
roxithromycin; oral
2.0
114.2
2110
13324
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.0
113.2
2098
13246
XQ800
NOMESCO Finland
Prick test
3.5
113.0
577
1785
R06AX22
ATC
ebastine; oral
2.4
106.9
1065
5047
DHA10
NOMESCO Finland
Biopsy of cavity of nose
19.1
106.8
166
90
J34.3
ICD-10 Finland
Hypertrophy of nasal turbinates
7.7
106.3
258
352
R03BB04
ATC
tiotropium bromide; inhalant
3.4
105.9
576
1867
R03AC13
ATC
formoterol; inhalant
4.6
104.0
384
884
J01.9
ICD-10 Finland
Acute sinusitis, unspecified
5.4
102.4
329
651
R75
ICPC
Sinusitis acute/chronic
4.4
101.3
394
955
D14.0
ICD-10 Finland
Benign neoplasm: Middle ear, nasal cavity and accessory sinuses
16.3
99.6
164
104
DMB10
NOMESCO Finland
Radical maxillary antrotomy
29.9
98.9
134
46
R03AC12
ATC
salmeterol; inhalant
5.1
98.3
331
690
Z88.6
ICD-10 Finland
Personal history of allergy to analgesic agent
150.3
97.5
103
7
A02BC05
ATC
esomeprazole; systemic
1.9
96.8
2039
13263
J32
ICD-10 Finland
Chronic sinusitis
19.8
96.6
148
77
4730A
ICD-9 Finland
Chronic sinusitis, Maxillary
9.7
95.8
201
215
4711A
ICD-9 Finland
Nasal polyps, Polypoid sinus degeneration
47.5
94.8
116
25
J33.1
ICD-10 Finland
Polypoid sinus degeneration
322.6
93.2
94
*
J33
ICD-10 Finland
Nasal polyp
21.0
92.6
139
68
N02BE01
ATC
paracetamol; systemic, rectal
2.2
92.2
4079
34653
A02BC02
ATC
pantoprazole; systemic
1.9
89.1
3050
23268
J01MA12
ATC
levofloxacin; systemic
2.3
87.9
976
4820
J01MA14
ATC
moxifloxacin; systemic
3.0
86.2
562
2054
R03AK11
ATC
formoterol and fluticasone; inhalant
6.0
86.0
248
429
SPAT1263
SPAT
Sampling
1.8
83.1
2061
13959
J01DA01
ATC
[U] cefalexin; systemic
1.8
82.1
3030
23359
J46
ICD-10 Finland
Status asthmaticus
6.2
81.5
231
391
R06AX13
ATC
loratadine; oral
2.3
81.5
896
4387
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
81.1
2292
16167
WX110
NOMESCO Finland
Local anesthesy
1.9
81.0
3357
26840
R03DA04
ATC
theophylline; systemic, rectal
4.6
79.3
295
681
J06.9
ICD-10 Finland
Acute upper respiratory infection, unspecified
1.8
79.2
2180
15201
R03AC03
ATC
terbutaline; inhalant
2.3
77.9
794
3736
J01
ICD-10 Finland
Acute sinusitis
3.8
77.4
355
994
N02AJ06
ATC
codeine and paracetamol; systemic
1.8
73.9
1873
12619
H65.3
ICD-10 Finland
Chronic mucoid otitis media
6.7
73.2
194
300
J32.3
ICD-10 Finland
Chronic sphenoidal sinusitis
44.8
71.3
88
20
DCA20
NOMESCO Finland
Insertion of ventilating tube through tympanic membrane
6.7
70.7
188
292
R06AX26
ATC
fexofenadine; oral
3.0
69.9
446
1598
J02AC01
ATC
fluconazole; systemic
1.8
69.4
1954
13529
J30.10
ICD-10 Finland
Allergic rhinitis due to pollen
3.4
68.8
362
1131
DPB00
NOMESCO Finland
Partial excision of frontal sinus
236.7
68.4
70
*
4224
FHL
Endonasal anthrostomy
10.4
68.3
137
135
J30.3
ICD-10 Finland
Other allergic rhinitis
4.2
67.4
270
669
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
2.1
66.9
870
4550
R01BA51
ATC
phenylpropanolamine, combinations; oral
2.4
65.9
653
3008
GD1DD
NOMESCO Finland
High resolution CT examination of lungs
3.5
64.2
316
936
XG410
NOMESCO Finland
Flow-volume spirometry
3.9
64.1
277
735
DCA10
NOMESCO Finland
Paracentesis of tympanic membrane
7.5
63.2
154
211
WX002
NOMESCO Finland
Sedation and analgesia
2.0
63.1
948
5247
J01MA02
ATC
ciprofloxacin; systemic
1.7
62.3
1769
12157
XG412
NOMESCO Finland
Flow-volume spirometry with bronchospasmolysis
3.2
62.1
351
1154
R03DC01
ATC
zafirlukast; oral
7.3
60.7
150
210
DM1QA
NOMESCO Finland
Paranasal sinuses X-ray examination in one projection
3.5
60.6
304
913
XX3DW
NOMESCO Finland
Time consuming IT work
2.4
60.0
545
2396
Z01.8
ICD-10 Finland
Other specified special examinations
1.9
59.3
1061
6251
J45.8
ICD-10 Finland
Mixed asthma
4.7
57.8
207
459
DM1CI
NOMESCO Finland
Very extensive cone beam CT of paranasal sinus
32.1
57.4
76
24
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.4
57.0
515
2255
J01FF01
ATC
clindamycin; systemic
1.8
55.3
1316
8494
R05
ICD-10 Finland
Cough
1.9
55.0
894
5067
ZXE10
NOMESCO Finland
More than one and less than three hours
1.7
55.0
1656
11465
J30.0
ICD-10 Finland
Vasomotor rhinitis
4.8
54.3
188
402
4226
FHL
Posterior radical surgery and possible etmoidectomy
13.4
54.3
96
73
R06.0
ICD-10 Finland
Dyspnoea
1.8
53.0
1050
6370
WX404
NOMESCO Finland
Intravenous generell anesthesy
1.8
53.0
1018
6116
J01DA08
ATC
[U] cefaclor; oral
2.2
52.5
590
2866
N02AX02
ATC
tramadol; systemic, rectal
1.6
52.0
1909
13893
H66.0
ICD-10 Finland
Acute suppurative otitis media
2.8
51.5
357
1339
H65.2
ICD-10 Finland
Chronic serous otitis media
8.0
51.2
119
152
R02
ICPC
Shortness of breath/dyspnoea
2.2
50.4
547
2615
J47
ICD-10 Finland
Bronchiectasis
6.7
49.7
130
198
GD1ED
NOMESCO Finland
Extensive high resolution CT examination of lungs
4.1
49.0
199
499
SPAT1028
SPAT
Ultrasound examination of paranasal sinuses
2.8
48.5
339
1278
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.6
48.3
1823
13277
A02BC03
ATC
lansoprazole; oral
1.7
48.0
1282
8497
49300
ICD-8 Finland
Asthma, bronchiale
4.7
47.7
168
366
J34.8
ICD-10 Finland
Other specified disorders of nose and nasal sinuses
7.4
47.5
116
160
WX402
NOMESCO Finland
General anaesthesia
1.9
47.3
814
4683
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
1.6
47.1
1597
11295
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
46.0
1291
8659
GX1L5
NOMESCO Finland
Exhaled nitric oxide analysis
14.1
45.8
79
57
ZXC99
NOMESCO Finland
Other special technic in surgery
43.5
45.4
56
13
ZXC60
NOMESCO Finland
Application of heat
5.0
45.0
149
304
J30.4
ICD-10 Finland
Allergic rhinitis, unspecified
3.6
45.0
213
610
R01AD
ATC
Corticosteroids
7.2
44.7
111
157
DHB10
NOMESCO Finland
Excision of lesion of internal nose
17.7
44.5
70
40
M01AE03
ATC
ketoprofen; systemic, rectal
1.6
44.4
1674
12116
D01AC20
ATC
imidazoles/triazoles in combination with corticosteroids; topical
1.7
44.4
1049
6682
R51.80
ICD-10 Finland
Headache
1.9
44.1
718
4038
M03BX02
ATC
tizanidine; oral
1.5
43.4
2917
24150
C01CA24
ATC
epinephrine; parenteral
2.6
43.4
348
1422
R01BA01
ATC
phenylpropanolamine; oral
2.7
43.0
318
1238
4732A
ICD-9 Finland
Chronic sinusitis, Ethmoidal
30.3
42.7
57
19
SPAT1310
SPAT
Counselling related to known health issue
1.6
42.1
1396
9747
50301
ICD-8 Finland
Chronic sinusitis, Maxillaris NUD
8.1
42.0
96
120
ZXE00
NOMESCO Finland
One hour or less
1.6
41.7
1761
13052
R74
ICPC
Upper respiratory infection acute
1.6
40.8
1306
9021
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
40.8
1826
13699
R05DA20
ATC
opium alkaloids and derivatives - combinations
1.6
39.1
1145
7707
50503
ICD-8 Finland
Nasal polyp, Ethmoidalis
38.1
38.7
49
13
S01XA20
ATC
artificial tears and other indifferent preparations; ophthalmic
1.5
38.2
1631
12050
M01AH05
ATC
etoricoxib; oral
1.5
37.9
2717
22464
Z03.89
ICD-10 Finland
Observation for other suspected diseases and conditions
2.0
37.7
556
3003
G47.3
ICD-10 Finland
Sleep apnoea
1.7
37.7
1005
6584
R01AX03
ATC
ipratropium bromide; nasal
4.4
37.5
140
325
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
1.6
37.4
1183
8115
R07
ICPC
Sneezing/nasal congestion
2.4
37.0
329
1417
ZXD20
NOMESCO Finland
Day surgery
1.9
36.5
609
3441
DNB10
NOMESCO Finland
Endonasal ethmoidectomy
68.8
36.0
41
6
NK6QA
NOMESCO Finland
Measurement of bone density from tow or more locations with X-ray
2.4
35.8
312
1329
SPAT1153
SPAT
Removal of sutures
1.6
35.4
1334
9528
DKW40
NOMESCO Finland
Ligature of artery of internal nose
34.9
35.0
45
13
S01GX01
ATC
cromoglicic acid; ophthalmic
1.7
34.9
889
5734
A02BC01
ATC
omeprazole; systemic
1.6
34.8
1137
7835
R06.2
ICD-10 Finland
Wheezing
2.8
34.7
235
869
S01CA01
ATC
dexamethasone and antiinfectives; ophthalmic (ophth., corticosteroids and antiinfectives in comb.)
1.6
34.4
1263
8953
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.6
34.4
1173
8167
N03AX16
ATC
pregabalin; oral
1.6
34.2
995
6649
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.7
34.1
853
5466
M01AE02
ATC
naproxen; oral, rectal
1.5
33.8
2530
20866
A02BA02
ATC
ranitidine; systemic
1.7
33.7
800
5050
4221
FHL
Polyp removal from the nasal cavity, sinus puncture or irrigation, or biopsy under general anesthesia or operating room
9.1
33.4
71
79
A06AC01
ATC
ispaghula (psylla seeds); oral
1.6
33.4
966
6438
J37.0
ICD-10 Finland
Chronic laryngitis
3.2
33.3
181
578
A02BC04
ATC
rabeprazole; oral
2.1
33.1
404
2018
A07AA02
ATC
nystatin; oral
2.5
32.8
281
1186
P01AB01
ATC
metronidazole; oral, rectal
1.5
32.5
1709
13085
D07AC01
ATC
betamethasone; topical
1.5
32.1
1447
10719
DMW00
NOMESCO Finland
Intubation of maxillary antrum
20.6
31.7
47
23
H66.9
ICD-10 Finland
Otitis media, unspecified
2.4
31.6
277
1183
3028
Kela drug reimbursment
Mepolizumab
53.2
31.3
37
7
297
Kela drug reimbursment
NA
53.2
31.3
37
7
UGC12
NOMESCO Finland
Flexible bronchoscopy
2.2
30.8
320
1486
J02AC02
ATC
itraconazole; systemic
1.7
30.8
812
5268
DM1BD
NOMESCO Finland
Extensive CT of paranasal sinuses and face area
12.0
30.6
56
47
R03BC03
ATC
nedocromil; inhalant
2.2
30.5
332
1575
D72.1
ICD-10 Finland
Eosinophilia
10.7
29.4
57
54
R06.5
ICD-10 Finland
Mouth breathing
2.0
29.1
413
2191
SPAT1058
SPAT
PEF monitoring instruction
2.1
29.1
350
1737
J20
ICD-10 Finland
Acute bronchitis
2.0
28.9
411
2179
4939X
ICD-9 Finland
Asthma, unspecified[ASTHMA BRONCHIALE NUD]
5.5
28.7
87
162
Z01.2
ICD-10 Finland
Dental examination
1.4
28.4
1782
14030
DFF00
NOMESCO Finland
Pure tone audiometry
2.0
28.4
377
1948
ZFX00
NOMESCO Finland
Use of balloon dilatation
36.3
28.3
36
10
N03AX12
ATC
gabapentin; oral
1.7
28.3
656
4092
SPAT1036
SPAT
Maxillary puncture
15.5
28.1
46
30
E0000UV
ATC
NA
1.4
27.9
1666
12979
R08
ICPC
Nose symptom/complaint other
2.9
27.9
174
612
SPAT1260
SPAT
Consultation of another employee
1.7
27.8
724
4666
SAA03
NOMESCO Finland
Extended examination of mouth
1.4
27.7
1672
13045
SPAT1312
SPAT
General health counselling
1.5
27.6
1341
10017
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
27.5
2143
17531
R03DX09
ATC
mepolizumab; parenteral
47.4
27.4
33
7
DNW99
NOMESCO Finland
Other operation on ethmoidal sinus and bone
47.4
27.4
33
7
WX290
NOMESCO Finland
Other blockade of nerve
1.4
26.8
1980
16012
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
26.6
2444
20530
Z01.1
ICD-10 Finland
Examination of ears and hearing
1.8
26.5
536
3206
M25.5
ICD-10 Finland
Pain in joint
1.5
26.5
1205
8867
J01DC04
ATC
cefaclor; oral
4.7
26.5
92
200
A01AB09
ATC
miconazole; local oral
2.0
26.4
354
1835
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
26.1
3168
27894
WZC30
NOMESCO Finland
Teaching
1.7
25.7
563
3451
H65.0
ICD-10 Finland
Acute serous otitis media
4.2
25.5
98
236
M03BC51
ATC
orphenadrine, combinations; systemic
1.5
25.1
1237
9229
50304
ICD-8 Finland
Chronic sinusitis, Ethmoidalis
58.3
25.0
29
5
SAA02
NOMESCO Finland
Basic examination of mouth
1.4
24.8
2842
24657
DMA00
NOMESCO Finland
Biopsy of maxillary antrum
21.3
24.7
36
17
Z71.2
ICD-10 Finland
Person consulting for explanation of investigation findings
1.5
24.6
951
6739
H04.10
ICD-10 Finland
Dry eye syndrome
1.9
24.4
408
2291
ZXB87
NOMESCO Finland
Balloon dilation, paranasal sinuses
27.7
24.4
33
12
DM1BI
NOMESCO Finland
Extensive cone beam CT of paranasal sinus
34.6
24.2
31
9
R05FB02
ATC
cough suppressants and expectorants
1.4
24.0
1496
11658
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.4
23.9
2305
19374
EMB10
NOMESCO Finland
Tonsillectomy
2.1
23.8
276
1348
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
23.7
1653
13140
J01MA01
ATC
ofloxacin; systemic
1.9
23.7
350
1880
UJF32
NOMESCO Finland
Coloscopy
1.5
23.6
982
7062
R01AC01
ATC
cromoglicic acid; nasal
2.4
23.4
198
831
SPAT1301
SPAT
No procedures
1.4
23.3
1217
9167
M01AB05
ATC
diclofenac; systemic, rectal
1.4
23.2
2954
25920
EB1SA
NOMESCO Finland
Dental X-ray, bite-wing X-ray on one side of the mouth
1.4
23.1
2180
18212
D82
ICPC
Teeth/gum disease
1.4
23.0
1497
11741
D07AB02
ATC
hydrocortisone butyrate; topical
1.4
22.9
1135
8453
H72.0
ICD-10 Finland
Central perforation of tympanic membrane
3.7
22.9
102
281
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.4
22.8
1151
8600
AA1AD
NOMESCO Finland
CT of head and brain
1.5
22.5
874
6182
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.5
22.5
797
5525
H02AB09
ATC
hydrocortisone; systemic
3.1
22.1
122
396
DMA10
NOMESCO Finland
Exploration of maxillary antrum
21.5
22.1
32
15
D07AC13
ATC
mometasone; topical
1.4
21.9
1185
8967
4239
FHL
Other measure in this category
9.6
21.7
44
46
R4110
NOMESCO Finland
Physiotherapy
0.6
21.5
537
7847
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.5
21.1
872
6243
CCD60
NOMESCO Finland
Transnasal dacryocystorhinostomy
8.7
21.0
45
52
XG499
NOMESCO Finland
Other fysiological examination of respiatory function
7.8
21.0
48
62
SHB00
NOMESCO Finland
Prepation and fitting of bite rail to mouth
1.7
20.9
425
2540
WX199
NOMESCO Finland
Other local analgesia
3.2
20.9
113
362
J01CA02
ATC
pivampicillin; oral
2.5
20.7
165
672
C05AA08
ATC
fluocortolone; rectal, topical
1.6
20.7
598
3939
SPAT1325
SPAT
Vaccination
1.4
20.6
1241
9558
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
20.6
296
1571
ZZR50
NOMESCO Finland
Mucoperiosteal flap
41.8
20.4
25
6
M54.5
ICD-10 Finland
Low back pain
1.4
20.4
1356
10626
M01AC06
ATC
meloxicam; systemic, rectal
1.4
20.2
1488
11856
DM1QA
SPAT
NA
3.1
19.8
111
365
4610A
ICD-9 Finland
Acute sinusitis, Maxillary
3.4
19.8
97
289
J01FA01
ATC
erythromycin; systemic
1.6
19.6
596
3971
AA3AI
NOMESCO Finland
Cone beam CT of facial bones
4.7
19.6
67
145
DM1ZD
NOMESCO Finland
NA
105.5
19.6
21
*
DNB40
NOMESCO Finland
Sublabial rhinotomy
105.5
19.6
21
*
AAE99
NOMESCO Finland
Other operation by cranial base approach
200.7
19.6
20
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
1.6
19.5
520
3350
R05
ICPC
Cough
1.5
19.4
869
6315
G50.1
ICD-10 Finland
Atypical facial pain
3.4
19.3
94
279
D07AD01
ATC
clobetasol; topical
1.5
19.3
626
4237
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.5
19.2
645
4401
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
1.7
19.2
399
2400
Z87.1
ICD-10 Finland
Personal history of diseases of the digestive system
1.3
19.2
1855
15399
J31.1
ICD-10 Finland
Chronic nasopharyngitis
5.9
19.1
53
90
NB1BA
NOMESCO Finland
Shoulder extensive X-ray examination without contrast
2.5
19.0
148
596
J35.0
ICD-10 Finland
Chronic tonsillitis
2.0
19.0
242
1226
SPAT1254
SPAT
Administration of medicine
1.6
18.9
515
3340
M30.1
ICD-10 Finland
Polyarteritis with lung involvement [Churg-Strauss]
34.4
18.9
24
7
DPB10
NOMESCO Finland
Partial excision of sphenoidal sinus
+∞
18.8
18
*
R04.0
ICD-10 Finland
Epistaxis
2.0
18.7
253
1314
NH3BA
NOMESCO Finland
Foot and toes extensive X-ray examination
2.4
18.7
167
721
ZZC00
NOMESCO Finland
Graft of fascia
27.9
18.7
25
9
CK2S4
NOMESCO Finland
Plain photography of ocular fundus
2.1
18.7
229
1144
M75.1
ICD-10 Finland
Rotator cuff syndrome
1.4
18.7
946
7034
J01.8
ICD-10 Finland
Other acute sinusitis
6.5
18.7
48
74
UJF30
NOMESCO Finland
Ileoscopy through colon
1.7
18.6
398
2414
DGW00
NOMESCO Finland
Dilatation of eustachian tube
12.3
18.5
33
27
EP1AE
NOMESCO Finland
Neck ultrasound examination
2.0
18.5
232
1168
H01
ICPC
Ear pain/earache
1.7
18.5
420
2590
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
18.5
200
948
SFA20
NOMESCO Finland
Filling on two surfaces of tooth
1.3
18.4
2525
22009
J30
ICD-10 Finland
Vasomotor and allergic rhinitis
3.5
18.3
87
254
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.5
18.3
641
4414
R51.81
ICD-10 Finland
Facial pain NOS
2.9
18.3
112
392
NK4XE
NOMESCO Finland
Joint ultrasound examination not elsewhere classified
1.9
18.2
285
1562
WX704
NOMESCO Finland
Intubation
1.8
18.1
299
1671
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
1.7
18.0
387
2351
R07.4
ICD-10 Finland
Chest pain, unspecified
1.4
17.8
984
7426
M79.6
ICD-10 Finland
Pain in limb
1.4
17.8
1390
11129
TPH04
NOMESCO Finland
Cathetrisation of vein
1.5
17.8
774
5585
N06AX21
ATC
duloxetine; oral
1.6
17.7
439
2774
B97.7
ICD-10 Finland
Papillomavirus as the cause of diseases classified to other chapters
8.9
17.6
37
42
A03FA02
ATC
cisapride; oral, rectal
1.9
17.5
277
1524
M79.1
ICD-10 Finland
Myalgia
1.6
17.5
514
3394
DJB10
NOMESCO Finland
Excision of septum of nose
180.6
17.5
18
*
J01CE02
ATC
phenoxymethylpenicillin; oral
1.3
17.5
3050
27407
SFC01
NOMESCO Finland
Adjuvant procedure of filling therapy
1.4
17.4
1108
8572
Z51.6
ICD-10 Finland
Desensitization to allergens
3.7
17.4
76
208
SPAT1104
SPAT
Monitoring of emergency patient
1.9
17.4
254
1358
4930B
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA CUM EXACERBATIONE]
7.0
17.3
42
60
L50.8
ICD-10 Finland
Other urticaria
3.2
17.3
93
299
395
Kela drug reimbursment
Dupilumab
42.1
17.3
21
5
N05CF02
ATC
zolpidem; oral
1.5
17.2
710
5064
L01
ICPC
Neck symptom/complaint
1.6
17.1
523
3486
A03
ICPC
Fever
1.5
17.1
630
4381
A98
ICPC
Health maint/preventive medicine
1.8
17.1
4531
43729
3027
Kela drug reimbursment
Benralizumab
50.2
17.0
20
*
R03DX10
ATC
benralizumab; systemic
50.2
17.0
20
*
DKW30
NOMESCO Finland
Cauterisation of artery of internal nose
6.4
17.0
44
69
SPAT1249
SPAT
Treatment-related counselling outside office
1.3
16.9
1591
13077
M51.3
ICD-10 Finland
Other specified intervertebral disc degeneration
1.7
16.8
337
2005
DM1AI
SPAT
NA
7.8
16.8
38
49
GD1AA
SPAT
NA
1.8
16.8
311
1806
L08
ICPC
Shoulder symptom/complaint
1.5
16.7
713
5113
DPB20
NOMESCO Finland
Obliteration of frontal sinus
63.5
16.7
19
*
J82
ICD-10 Finland
Pulmonary eosinophilia, not elsewhere classified
12.7
16.6
29
23
Z01.9
ICD-10 Finland
Special examination, unspecified
2.0
16.5
229
1202
AAK40
NOMESCO Finland
Closure of cerebrospinal fluid fistula
17.9
16.4
25
14
WX720
NOMESCO Finland
Own respiration
2.3
16.4
160
722
DMB30
NOMESCO Finland
Transmaxillary excision of lesion of maxillary antrum
20.1
16.4
24
12
K02.1
ICD-10 Finland
Caries of dentine
1.3
16.3
2450
21466
H68.1
ICD-10 Finland
Obstruction of Eustachian tube
3.6
16.2
73
205
SHA02
NOMESCO Finland
Correction of physiology of bite - basic therapy visit
1.8
16.2
279
1581
R91
ICD-10 Finland
Abnormal findings on diagnostic imaging of lung
1.7
16.1
334
2008
E27.3
ICD-10 Finland
Drug-induced adrenocortical insufficiency
7.0
16.1
39
56
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.5
16.0
578
4002
SPAT1211
SPAT
Application of soft bandage
1.7
16.0
337
2034
251
Kela drug reimbursment
NA
47.6
16.0
19
*
D11AH05
ATC
dupilumab; topical
47.6
16.0
19
*
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
1.7
15.9
344
2090
H92.0
ICD-10 Finland
Otalgia
2.0
15.9
202
1027
K58.0
ICD-10 Finland
Irritable bowel syndrome with diarrhoea
1.9
15.9
230
1226
R78
ICPC
Acute bronchitis/bronchiolitis
2.9
15.8
96
334
L50.9
ICD-10 Finland
Urticaria, unspecified
2.3
15.7
146
647
S18
ICPC
Laceration/cut
1.3
15.7
1593
13201
T78.4
ICD-10 Finland
Allergy, unspecified
2.1
15.7
189
937
R01AC02
ATC
levocabastine; nasal
2.4
15.7
134
570
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.5
15.7
572
3968
SPAT1262
SPAT
Handing over of treatment supplies
1.5
15.7
664
4752
R81
ICPC
Pneumonia
2.4
15.6
132
557
N06AA09
ATC
amitriptyline; systemic
1.7
15.5
370
2312
G04CA01
ATC
alfuzosin; oral
1.6
15.4
406
2608
SPAT1255
SPAT
Intravenous administration of medicine
1.8
15.4
253
1411
J01.3
ICD-10 Finland
Acute sphenoidal sinusitis
12.3
15.3
27
22
R5140
NOMESCO Finland
Monitoring the use of the aid
1.6
15.2
423
2750
GD1AD
NOMESCO Finland
Thorax CT examination
2.1
15.2
164
778
N06AX11
ATC
mirtazapine; oral
1.3
15.1
1226
9826
J01.2
ICD-10 Finland
Acute ethmoidal sinusitis
23.4
15.1
21
9
I49.9
ICD-10 Finland
Cardiac arrhythmia, unspecified
1.6
15.1
427
2791
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
1.6
15.0
408
2640
Z03.8
ICD-10 Finland
Observation for other suspected diseases and conditions
2.1
14.9
167
805
49302
ICD-8 Finland
Asthma, Rhinitis allergica cum asthmate bronchiali
5.0
14.8
47
95
M03BC01
ATC
orphenadrine (citrate); systemic
1.4
14.8
992
7710
R5110
NOMESCO Finland
Evaluation of the need for aids, the testing, fitting and choice of the aid, instruction in use and delivery of it
1.6
14.8
453
3017
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.3
14.8
1155
9198
G44.2
ICD-10 Finland
Tension-type headache
1.5
14.7
516
3545
K08.1
ICD-10 Finland
Loss of teeth due to accident, extraction or local periodontal disease
1.6
14.6
364
2303
WX320
NOMESCO Finland
Spinalanesthesy
1.4
14.6
833
6305
DKW99
NOMESCO Finland
Other procedures for control of epistaxis
11.9
14.5
26
22
J40
ICD-10 Finland
Bronchitis, not specified as acute or chronic
2.5
14.5
110
440
H66.3
ICD-10 Finland
Other chronic suppurative otitis media
6.0
14.5
39
65
J00
ICD-10 Finland
Acute nasopharyngitis [common cold]
2.6
14.5
102
390
H65.1
ICD-10 Finland
Other acute nonsuppurative otitis media
4.4
14.5
52
120
JN3BD
NOMESCO Finland
Extensive abdominal CT
1.6
14.4
401
2610
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
1.6
14.4
354
2231
L20.9
ICD-10 Finland
Atopic dermatitis, unspecified
2.2
14.4
146
673
Z3231
NOMESCO Finland
Registered nurse
0.7
14.3
608
8132
4700A
ICD-9 Finland
Deflected nasal septum[DEFORMATIO SEPTI NASI]
3.2
14.3
73
227
K58.9
ICD-10 Finland
Irritable bowel syndrome without diarrhoea
2.3
14.3
138
621
50300
ICD-8 Finland
Chronic sinusitis, Maxillaris cum empyemate
7.1
14.2
34
48
UKC02
NOMESCO Finland
Cystoscopy
1.5
14.2
530
3691
WQ000
NOMESCO Finland
Hyposensibilisation
5.5
14.1
41
75
K30
ICD-10 Finland
Functional dyspepsia
1.6
14.1
390
2534
SPAT1097
SPAT
Recording of ECG
1.5
14.0
503
3472
AA1CG
NOMESCO Finland
Extensive MRI examination of brain with high intensity magnet
1.7
14.0
314
1927
F45.8
ICD-10 Finland
Other somatoform disorders
1.7
14.0
282
1678
TCC30
NOMESCO Finland
Intubation of lacrimal canaliculus/duct
5.6
14.0
40
72
4227
FHL
Forehead cavity drainage
10.9
14.0
26
24
XG480
NOMESCO Finland
Histamine provocation of respiratroy tract
3.2
13.9
73
232
M01AH01
ATC
celecoxib; oral (coxibs)
1.4
13.9
677
4972
M70.6
ICD-10 Finland
Trochanteric bursitis
1.6
13.9
399
2619
E000002
ATC
NA
1.5
13.8
436
2922
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.4
13.8
643
4681
W01
ICD-10 Finland
Fall on same level from slipping, tripping and stumbling
1.3
13.8
1022
8058
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.4
13.8
703
5206
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.5
13.7
567
4038
DC1AD
NOMESCO Finland
Temporalbone CT
3.5
13.6
63
183
L50.3
ICD-10 Finland
Dermatographic urticaria
2.9
13.6
80
276
SHA01
NOMESCO Finland
Correction of physiology of bite - simple therapy visit
1.5
13.5
424
2840
A03CA02
ATC
clidinium and psycholeptics; oral
1.9
13.5
207
1127
4738X
ICD-9 Finland
Chronic sinusitis, Other chronic sinusitis
34.1
13.5
17
5
O99.5
ICD-10 Finland
Diseases of the respiratory system complicating pregnancy, childbirth and the puerperium
4.7
13.5
45
97
M01AX17
ATC
nimesulide; oral
1.4
13.4
896
6946
N02CC01
ATC
sumatriptan; nasal, systemic, rectal
1.5
13.4
542
3837
H04.5
ICD-10 Finland
Stenosis and insufficiency of lacrimal passages
2.9
13.4
80
278
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.3
13.4
1307
10719
4931A
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA SINE EXACERBATIONE]
5.6
13.4
38
68
NGD05
NOMESCO Finland
Partial excision of meniscus of knee, arthroscopic
1.5
13.4
460
3146
NH1BA
NOMESCO Finland
Ankle extensive X-ray examination
2.4
13.4
113
480
J01GB01
ATC
tobramycin; inhalant, parenteral
25.8
13.3
18
7
R03AL02
ATC
salbutamol and ipratropium bromide; inhalant
4.6
13.3
45
98
NA1BG
NOMESCO Finland
Cervical spine MRI examination with high intensity magnet
1.8
13.3
217
1208
WX723
NOMESCO Finland
CPAP therapy
2.0
13.3
162
809
W22
ICD-10 Finland
Striking against or struck by other object(s)
1.8
13.2
247
1438
NA3CG
NOMESCO Finland
Lumbar spine extensive MRI examination with high intensity magnet
2.0
13.2
159
791
SAA04
NOMESCO Finland
Special inverstigation of mouth
1.9
13.2
208
1146
Z00.0
ICD-10 Finland
General medical examination
1.4
13.2
668
4941
NG1AA
NOMESCO Finland
Knee X-ray examination without contrast
1.5
13.1
406
2712
D80.1
ICD-10 Finland
Nonfamilial hypogammaglobulinaemia
7.5
13.1
30
40
SFA30
NOMESCO Finland
Filling on tree or more surfaces of tooth
1.3
13.0
1668
14168
R50.9
ICD-10 Finland
Fever, unspecified
1.5
13.0
496
3469
DJW99
NOMESCO Finland
Other operation on septum of nose
16.7
13.0
20
12
H05.0
ICD-10 Finland
Acute inflammation of orbit
16.7
13.0
20
12
JN3AD
NOMESCO Finland
Abdominal CT examination
1.7
12.9
281
1713
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.5
12.9
448
3074
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
1.5
12.8
395
2634
R52.2
ICD-10 Finland
Other chronic pain
2.2
12.8
130
601
WX400
NOMESCO Finland
Inhalation anesthesy
1.9
12.8
181
959
H90.3
ICD-10 Finland
Sensorineural hearing loss, bilateral
1.5
12.8
485
3390
M02AA07
ATC
piroxicam; topical
1.3
12.7
1337
11064
R03AL09
ATC
formoterol, glycopyrronium bromide and beclometasone; inhalant
3.0
12.7
73
247
R51
ICD-10 Finland
Headache
1.8
12.7
204
1132
R29.8
ICD-10 Finland
Other and unspecified symptoms and signs involving the nervous and musculoskeletal systems
1.6
12.6
314
1987
ND2AA
NOMESCO Finland
Hand and fingers X-ray examination
1.6
12.5
333
2142
R03AL01
ATC
fenoterol and ipratropium bromide; inhalant
2.5
12.5
94
375
DNB30
NOMESCO Finland
Excision of lesion of ethmoidal sinus
17.3
12.5
19
11
J01EE01
ATC
sulfamethoxazole and trimethoprim; systemic
1.8
12.5
228
1318
EP1CG
NOMESCO Finland
Extensive MRI examination of soft tissue of neck with high intesity magnet
3.6
12.5
55
154
D07CA01
ATC
hydrocortisone and antibiotics; topical
1.5
12.4
481
3372
U07.2
ICD-10 Finland
COVID-19, virus not identified
1.4
12.4
697
5248
R06AE08
ATC
NA
3.7
12.3
52
141
R13
ICD-10 Finland
Dysphagia
1.8
12.2
219
1261
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.3
12.2
1142
9292
K04.0
ICD-10 Finland
Pulpitis
1.5
12.2
397
2681
R05DA01
ATC
ethylmorphine; oral
1.6
12.2
296
1858
R42
ICD-10 Finland
Dizziness and giddiness
1.4
12.1
724
5502
A01AB04
ATC
amphotericin B; local oral
2.0
12.1
158
815
J05AB01
ATC
aciclovir; systemic
1.4
12.1
790
6095
1210
FHL
Anthroscopy
7.7
12.1
27
35
TGC00
NOMESCO Finland
Bronchial lavation
2.4
12.1
101
427
C08DA01
ATC
verapamil; systemic
2.1
12.1
137
666
R01AC07
ATC
nedocromil; nasal
5.4
12.0
35
65
CJE20
NOMESCO Finland
Phakoemulsification with implantation of artificial lens in posterior chamber
1.4
12.0
733
5592
A06AC51
ATC
ispaghula, combinations; systemic
1.9
12.0
181
985
M53.0
ICD-10 Finland
Cervicocranial syndrome
1.6
12.0
319
2055
SHA03
NOMESCO Finland
Correction of physiology of bite - demanding therapy visit
2.1
12.0
132
636
JBC01
NOMESCO Finland
Laparoscopic gastro-oesophageal antireflux operation
2.5
11.9
90
359
WX780
NOMESCO Finland
Remote monitoring CPAP
1.9
11.9
165
870
XQ820
NOMESCO Finland
Exposure to medicinal substance
6.0
11.9
32
54
R06AX18
ATC
acrivastine; oral
2.2
11.9
124
582
C09CA06
ATC
candesartan; oral
1.4
11.9
788
6093
G04BD12
ATC
mirabegron; oral
1.6
11.8
313
2012
Z01.0
ICD-10 Finland
Examination of eyes and vision
1.4
11.8
581
4271
4931B
ICD-9 Finland
Asthma, Intrinsic asthma[INTRINSIC ASTHMA CUM EXACERBATIONE]
8.4
11.8
25
30
R03AK
ATC
Adrenergics in combination with corticosteroids or other drugs, excl. anticholinergics
5.8
11.7
32
55
EB1AI
NOMESCO Finland
Cone beam imaging of teeth and jaws (one quarter)
2.7
11.7
78
291
J01X
ATC
OTHER ANTIBACTERIALS
4.3
11.7
42
98
CS494
NOMESCO Finland
Other visual field testing
2.7
11.7
79
298
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.0
11.6
152
784
-44
ICPC
Preventive immunization/medic
1.6
11.6
279
1749
XQ802
NOMESCO Finland
Epicutan test
1.9
11.6
166
885
H60.9
ICD-10 Finland
Otitis externa, unspecified
1.7
11.6
251
1530
R03AK04
ATC
salbutamol and sodium cromoglicate; inhalant
5.5
11.6
33
60
NF1AA
NOMESCO Finland
Hip X-ray examination
1.6
11.6
272
1694
AA1BG
NOMESCO Finland
Standard MRI examination of brain with high intensity magnet
1.6
11.6
310
2000
PA7AD
NOMESCO Finland
CT angiography of head and neck vasculature
2.4
11.5
98
419
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.2
11.5
111
503
D02AE01
ATC
carbamide; topical
1.7
11.4
236
1418
H71
ICPC
Acute otitis media/myringitis
3.2
11.4
58
182
50099
ICD-8 Finland
Hypertrophy of tonsils and adenoids
1.5
11.4
426
2963
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
1.7
11.4
252
1546
M02AA10
ATC
ketoprofen; topical
1.4
11.3
568
4185
EMB30
NOMESCO Finland
Adenotomy
2.8
11.3
72
262
J01DB05
ATC
cefadroxil; oral
1.8
11.3
177
974
SPAT1220
SPAT
Assessment of need for rehabilitation and/or rehabilitation plan
1.7
11.3
226
1346
K08.80
ICD-10 Finland
Toothache NOS
1.6
11.3
304
1964
SPAT1215
SPAT
Assessment of need for medical rehabilitation
1.9
11.2
157
832
NG1BA
NOMESCO Finland
Knee extensive X-ray examination
2.5
11.1
85
342
XG405
NOMESCO Finland
Education on PEF monitoring
2.8
11.0
69
248
4618A
ICD-9 Finland
Acute sinusitis, Other acute sinusitis
7.1
11.0
26
37
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
1.8
11.0
195
1118
EB1AD
NOMESCO Finland
Cone beam CT of teeth and jaws (one quarter)
5.6
11.0
31
56
L15
ICPC
Knee symptom/complaint
1.3
11.0
720
5550
M19.0
ICD-10 Finland
Primary arthrosis of other joints
1.5
10.9
338
2255
J01AA04
ATC
lymecycline; systemic
1.4
10.9
518
3778
H03AA01
ATC
levothyroxine sodium; systemic
1.3
10.9
823
6486
J22
ICD-10 Finland
Unspecified acute lower respiratory infection
1.8
10.9
170
938
46100
ICD-8 Finland
Acute sinusitis, Maxillaris
2.3
10.8
99
439
TDA90
NOMESCO Finland
Removal wax from ear
3.1
10.8
59
195
LEG12
NOMESCO Finland
Transobturatoric tape
2.8
10.8
66
235
L90
ICPC
Osteoarthrosis of knee
1.7
10.8
199
1158
N06AX16
ATC
venlafaxine; oral
1.4
10.7
545
4023
S02CA02
ATC
flumetasone and antiinfectives; otic
1.7
10.7
205
1202
A03FA01
ATC
metoclopramide; systemic, rectal
1.3
10.7
742
5766
L03
ICPC
Low back symptom/complaint
1.3
10.7
879
7010
M77.1
ICD-10 Finland
Lateral epicondylitis
1.6
10.7
291
1884
DHB30
NOMESCO Finland
Polypectomy of choana through maxillary antrum
60.1
10.6
12
*
N02CC03
ATC
zolmitriptan; nasal, oral
1.7
10.6
214
1277
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.4
10.6
632
4797
112
Kela drug reimbursment
Severe psychotic and other severe mental disorders
0.5
10.6
108
1960
EB1CI
NOMESCO Finland
Cone beam imaging of teeth and jaws (3-4 quarters)
4.0
10.5
41
104
DM1DG
NOMESCO Finland
Paranasal sinuses and face area very extensive MRI examination with high intensity magnet
10.0
10.5
20
20
M54.4
ICD-10 Finland
Lumbago with sciatica
1.4
10.5
615
4658
E84.9
ICD-10 Finland
Cystic fibrosis, unspecified
110.2
10.4
11
*
R03BB01
ATC
ipratropium bromide; inhalant
2.2
10.3
105
489
A02BA04
ATC
nizatidine; systemic
1.6
10.3
251
1584
F29
ICD-10 Finland
Unspecified nonorganic psychosis
0.3
10.2
28
813
R53
ICD-10 Finland
Malaise and fatigue
1.3
10.2
684
5287
N01
ICPC
Headache
1.5
10.2
350
2392
N05CF01
ATC
zopiclone; oral
1.3
10.2
1110
9182
L17
ICPC
Foot/toe symptom/complaint
1.3
10.2
870
6968
4779A
ICD-9 Finland
Allergic rhinitis, Cause unspecified
3.3
10.2
49
149
K03.64
ICD-10 Finland
Dental calculus supragingival
1.3
10.1
1075
8862
XG404
NOMESCO Finland
Peak expiratory flow (PEF) measurement
3.8
10.1
41
108
NBG15
NOMESCO Finland
Acromioplastia, arthroscopic
1.6
10.1
254
1613
M54.2
ICD-10 Finland
Cervicalgia
1.6
10.1
260
1661
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
1.8
10.0
159
881
XKD00
NOMESCO Finland
Uroflowmetry
1.4
10.0
504
3719
JC2KB
NOMESCO Finland
Functional X-ray examination of swallowing
3.5
10.0
45
130
N02AA05
ATC
oxycodone; systemic
1.4
10.0
430
3081
N05BA04
ATC
oxazepam; oral
1.3
10.0
883
7107
Z04.3
ICD-10 Finland
Examination and observation following other accident
2.4
10.0
82
347
R03DA05
ATC
aminophylline; systemic, rectal
4.6
10.0
33
72
E000007
ATC
NA
1.7
10.0
205
1234
E84.0
ICD-10 Finland
Cystic fibrosis with pulmonary manifestations
40.1
10.0
12
*
R01AD04
ATC
flunisolide; nasal
3.7
9.9
41
110
M01AC01
ATC
piroxicam; systemic, rectal
1.4
9.9
463
3368
NA1AD
NOMESCO Finland
Cervical spine CT examination
1.9
9.9
136
717
R29
ICPC
Respiratory symptom/complaint other
1.6
9.9
226
1401
M50.1
ICD-10 Finland
Cervical disc disorder with radiculopathy
1.8
9.9
178
1030
SPAT1257
SPAT
Teaching of medicine inhalation technique
2.0
9.9
121
611
R44
ICPC
Respiratory, Preventive immunization/medic
3.2
9.9
50
158
SCA02
NOMESCO Finland
Analysis and advice of nutrition with regard to dentistry
1.5
9.9
340
2325
344
Kela drug reimbursment
Omalizumab
16.7
9.9
15
9
E000001
ATC
NA
1.3
9.8
759
5990
G01AF04
ATC
miconazole; vaginal
1.8
9.8
177
1025
R43.0
ICD-10 Finland
Anosmia
3.7
9.8
41
112
D01BA02
ATC
terbinafine; oral; topical
1.3
9.7
938
7633
F20.00
ICD-10 Finland
Paranoid schizophrenia continuous
0.2
9.7
7
422
DFF59
NOMESCO Finland
Other assessment of balance
3.2
9.7
48
149
R03AC04
ATC
fenoterol; inhalant
6.5
9.7
24
37
J31
ICD-10 Finland
Chronic rhinitis, nasopharyngitis and pharyngitis
3.3
9.7
47
144
DAX08
NOMESCO Finland
Fitting of hearing aid
2.0
9.7
117
587
SPAT1043
SPAT
Audiometry
1.5
9.7
310
2088
M79.0
ICD-10 Finland
Rheumatism, unspecified
1.9
9.7
134
709
X59
ICD-10 Finland
Exposure to unspecified factor
1.3
9.6
681
5304
J41.1
ICD-10 Finland
Mucopurulent chronic bronchitis
5.3
9.6
28
53
M01AE01
ATC
ibuprofen; systemic, rectal
1.3
9.6
4070
38980
XG470
NOMESCO Finland
Measurement of diffusion capastity of the lungs
2.2
9.6
96
447
ZZF00
NOMESCO Finland
Graft of adipose tissue
3.3
9.6
46
140
K21
ICD-10 Finland
Gastro-oesophageal reflux disease
1.7
9.5
182
1071
G03BA03
ATC
testosterone; systemic, rectal, sublingual, transdermal
1.7
9.5
196
1180
TNX10
NOMESCO Finland
Arthrocentesis, unspecified region, unspecified region
1.6
9.5
243
1547
L16
ICPC
Ankle symptom/complaint
1.5
9.5
333
2285
G96.0
ICD-10 Finland
Cerebrospinal fluid leak
15.0
9.5
15
10
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
1.6
9.5
255
1651
N05AH02
ATC
clozapine; systemic
0.2
9.4
8
433
J98.0
ICD-10 Finland
Diseases of bronchus, not elsewhere classified
7.5
9.4
21
28
G03CA03
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
1.2
9.4
1387
11875
NGF25
NOMESCO Finland
Operation for osteochondritis of knee, arthroscopic
1.6
9.3
252
1630
DJW00
NOMESCO Finland
Removal of local lesion of nasal septum
21.7
9.3
13
6
R22.0
ICD-10 Finland
Localized swelling, mass and lump, head
2.0
9.3
110
547
4212
FHL
Maxillapremmaxilla opening septum resection and reconstruction
4.0
9.3
35
87
SPAT1238
SPAT
Brief therapy
2.4
9.3
77
327
EB1MA
NOMESCO Finland
Cephalometry with X-ray
2.3
9.3
80
347
S03CA04
ATC
hydrocortisone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.0
9.3
112
563
X58
ICD-10 Finland
Exposure to other specified factors
1.4
9.2
508
3805
ZX112
NOMESCO Finland
Subcutaneous
2.4
9.2
74
311
D07BB04
ATC
hydrocortisone butyrate and antiseptics; topical
1.4
9.2
454
3336
R06AX12
ATC
terfenadine; oral
1.7
9.1
173
1018
K07.60
ICD-10 Finland
Snapping jaw
1.7
9.1
183
1092
1470
FHL
Rectoscopy
3.6
9.1
39
109
G43.9
ICD-10 Finland
Migraine, unspecified
1.6
9.1
213
1332
DKW00
NOMESCO Finland
Cauterisation of mucosa of nose
3.3
9.1
43
130
D01AE16
ATC
amorolfine; topical
1.4
9.1
385
2751
4742A
ICD-9 Finland
Chronic disease of tonsils and adenoids, Adenoid vegetations
2.5
9.1
70
288
DHB45
NOMESCO Finland
Turbinate reduction
11.5
9.0
16
14
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.6
9.0
258
1695
F45.4
ICD-10 Finland
Persistent somatoform pain disorder
2.5
9.0
69
282
I84.2
ICD-10 Finland
Internal hemorrhoids without complication
1.5
8.9
275
1837
NA3AD
NOMESCO Finland
Lumbar spine and sacrum CT examination
2.2
8.9
88
405
D11
ICPC
Diarrhoea
1.4
8.9
394
2838
L13
ICPC
Hip symptom/complaint
1.4
8.9
483
3607
M80.4
ICD-10 Finland
Drug-induced osteoporosis with pathological fracture
6.1
8.9
23
38
M67.4
ICD-10 Finland
Ganglion
1.6
8.9
233
1498
C30.0
ICD-10 Finland
Malignant neoplasm: Nasal cavity
12.5
8.8
15
12
M23.8
ICD-10 Finland
Other internal derangements of knee
1.8
8.8
143
800
J01CA08
ATC
pivmecillinam; oral
1.2
8.8
1380
11870
D80.3
ICD-10 Finland
Selective deficiency of immunoglobulin G [IgG] subclasses
7.2
8.7
20
28
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.4
8.7
383
2756
AA1DG
NOMESCO Finland
Very extensive MRI examination of brain with high intensity magnet
2.0
8.7
106
537
R05CB13
ATC
dornase alfa (desoxyribonuclease); inhalant
50.1
8.7
10
*
304
Kela drug reimbursment
Dornase alfa
50.1
8.7
10
*
K59.1
ICD-10 Finland
Functional diarrhoea
1.7
8.7
167
989
O80.8
ICD-10 Finland
Other single spontaneous delivery
1.9
8.7
128
695
-54
ICPC
Repair/fix-suture/cast/prosth device
2.1
8.6
91
433
NBL00
NOMESCO Finland
Suture or reinsertation of rotator cuff of shoulder
1.7
8.6
190
1169
J34.0
ICD-10 Finland
Abscess, furuncle and carbuncle of nose
6.1
8.6
22
36
120
Kela drug reimbursment
Hypogammaglobulinaemia
6.1
8.6
22
36
4930A
ICD-9 Finland
Asthma, Extrinsic asthma[EXTRINSIC ASTHMA SINE EXACERBATIONE]
2.9
8.6
50
174
H66.1
ICD-10 Finland
Chronic tubotympanic suppurative otitis media
5.2
8.6
25
48
R83
ICPC
Respiratory infection other
1.3
8.6
931
7678
J35.8
ICD-10 Finland
Other chronic diseases of tonsils and adenoids
4.6
8.6
28
61
ND1BA
NOMESCO Finland
Wrist extensive X-ray examination
2.2
8.5
80
360
R49.08
ICD-10 Finland
Other specified dysphonia
2.2
8.5
85
393
M53.1
ICD-10 Finland
Cervicobrachial syndrome
1.4
8.5
406
2963
DAX00
NOMESCO Finland
Adjustment or review of hearing aid
1.9
8.5
115
606
NH3AA
NOMESCO Finland
Foot and toes X-ray examination
1.5
8.5
283
1922
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
1.6
8.5
221
1418
4719X
ICD-9 Finland
Nasal polyps, Unspecified nasal polyp
20.0
8.5
12
6
J06BA01
ATC
immunoglobulins, normal human, for extravascular adm.; systemic
6.4
8.5
21
33
NA1CG
NOMESCO Finland
Cervical spine extensive MRI examination with high intensity magnet
2.3
8.4
75
332
SGC00
NOMESCO Finland
Local medication of root channels of tooth
1.4
8.4
410
3003
NDM40
NOMESCO Finland
Discission of sheath of tendon of wrist or hand
2.0
8.4
99
494
DPW00
NOMESCO Finland
Intubation of frontal sinus
90.2
8.4
9
*
AAE05
NOMESCO Finland
Nasoendoscopic closure of cerebrospinal fluid fistula
90.2
8.4
9
*
OAB43
SPAT
NA
1.3
8.4
671
5314
R03BB07
ATC
umeclidinium bromide; inhalant
3.7
8.4
35
96
JHB30
NOMESCO Finland
Rubber band ligature of haemorrhoids or prolapse of mucosa
1.6
8.4
212
1349
Z96.1
ICD-10 Finland
Presence of intraocular lens
1.5
8.4
305
2115
R03AK03
ATC
[D] fenoterol & other drugs for obstructive airway dis; inhalant
1.8
8.4
139
786
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
1.5
8.4
320
2240
ZY020
NOMESCO Finland
Telephone, letter or other consultation without direct patient contact
1.6
8.3
233
1524
H25.8
ICD-10 Finland
Other senile cataract
1.5
8.3
254
1694
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
1.8
8.3
125
684
J35.2
ICD-10 Finland
Hypertrophy of adenoids
2.6
8.3
55
209
DM1CG
NOMESCO Finland
Paranasal sinuses and face area extensive MRI examination with high intensity magnet
8.5
8.3
17
20
H10
ICD-10 Finland
Conjunctivitis
1.6
8.3
208
1325
LX1AE
NOMESCO Finland
Gynecological ultrasound examination as part of clinical examination
1.4
8.3
352
2515
R20.2
ICD-10 Finland
Paraesthesia of skin
1.6
8.3
231
1511
R03AL08
ATC
vilanterol, umeclidinium bromide and fluticasone furoate; inhalant
2.8
8.2
50
180
E03.9
ICD-10 Finland
Hypothyroidism, unspecified
1.4
8.2
375
2716
G01AF02
ATC
clotrimazole; vaginal
1.8
8.2
128
707
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.3
8.2
933
7734
M75.4
ICD-10 Finland
Impingement syndrome of shoulder
1.5
8.2
247
1645
L20.0
ICD-10 Finland
Besnier prurigo
1.6
8.2
224
1457
M48.0
ICD-10 Finland
Spinal stenosis
1.4
8.2
351
2512
D80.9
ICD-10 Finland
Immunodeficiency with predominantly antibody defects, unspecified
6.0
8.1
21
35
G01AF05
ATC
econazole; vaginal
1.5
8.1
293
2028
-31
ICPC
Medical examin/health eval partial
1.6
8.1
220
1428
R03DX05
ATC
omalizumab; parenteral
17.2
8.1
12
7
B01AF01
ATC
rivaroxaban; oral
1.4
8.1
351
2521
R03CC02
ATC
salbutamol; systemic
1.7
8.1
166
1001
Z37.0
ICD-10 Finland
Single live birth
0.6
8.0
115
1909
EB1BI
NOMESCO Finland
Cone beam imaging of teeth and jaws (1–2 quarters)
2.5
8.0
62
254
D83.9
ICD-10 Finland
Common variable immunodeficiency, unspecified
22.0
8.0
11
5
R35
ICD-10 Finland
Polyuria
1.6
8.0
200
1273
SDA02
NOMESCO Finland
Parodonthologic therapy
1.2
8.0
1242
10657
NG2AA
NOMESCO Finland
Patella X-ray examination
2.1
7.9
89
437
H53.1
ICD-10 Finland
Subjective visual disturbances
1.6
7.9
209
1348
WZA90
NOMESCO Finland
Other doctors statement
1.3
7.9
833
6837
N40
ICD-10 Finland
Hyperplasia of prostate
1.3
7.9
578
4518
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.4
7.9
416
3087
XKC03
NOMESCO Finland
Water cystometry
1.9
7.9
104
543
TNX50
NOMESCO Finland
Removal of cutom molded cast and internal stretch
1.7
7.9
161
968
NB1CM
NOMESCO Finland
Shoulder and humerus extensive MRI examination with 3 Tesla magnet
6.6
7.9
19
29
SBB10
NOMESCO Finland
Teeth copy
1.6
7.8
211
1369
NE1BG
NOMESCO Finland
Pelvic, hip and femur MRI examination with high intensity magnet
1.9
7.8
105
552
S03CA01
ATC
dexamethasone and antiinfectives; ophthalmic, otic (ophth. and otological prep., corticosteroids and antiinfectives in comb.)
2.1
7.8
86
420
K13.79
ICD-10 Finland
Change in the oral mucosa UNS
2.0
7.8
88
434
S46.0
ICD-10 Finland
Injury of muscle(s) and tendon(s) of the rotator cuff of shoulder
1.5
7.8
280
1935
R00.2
ICD-10 Finland
Palpitations
1.5
7.8
239
1595
R23.3
ICD-10 Finland
Spontaneous ecchymoses
2.4
7.8
61
254
SHA04
NOMESCO Finland
Correction of physiology of bite - very demanding therapy visit
2.7
7.7
50
187
M23.2
ICD-10 Finland
Derangement of meniscus due to old tear or injury
1.4
7.7
410
3054
J03.9
ICD-10 Finland
Acute tonsillitis, unspecified
1.7
7.7
169
1038
R32
ICD-10 Finland
Unspecified urinary incontinence
2.0
7.7
87
430
V01AA02
ATC
grass pollen; systemic
5.5
7.7
21
38
S01EE05
ATC
tafluprost; ophthalmic
2.0
7.6
93
472
H53.2
ICD-10 Finland
Diplopia
1.9
7.6
101
529
-1
NOMESCO Finland
NA
1.2
7.6
1289
11150
G04CB01
ATC
finasteride; oral (testosterone-5-alpha reductase inhibitors)
1.5
7.6
266
1833
F20.9
ICD-10 Finland
Schizophrenia, unspecified
0.3
7.6
11
432
WX204
NOMESCO Finland
Axillary plexus blockaced
1.9
7.5
111
606
R5130
NOMESCO Finland
Repair work or maintenance done on the aid
2.1
7.5
85
417
M65.4
ICD-10 Finland
Radial styloid tenosynovitis [de Quervain]
2.0
7.5
90
455
FN1AD
NOMESCO Finland
CT of coronary arteries
2.4
7.5
59
247
Z3226
NOMESCO Finland
Physiotherapist
0.7
7.5
382
5000
NA2BG
NOMESCO Finland
Thoracal spine MRI examination with high intensity magnet
2.0
7.4
87
434
M23.9
ICD-10 Finland
Internal derangement of knee, unspecified
1.4
7.4
297
2098
4451
FHL
Guitar cutting
1.9
7.4
102
543
DKW10
NOMESCO Finland
Packing of anterior cavity of nose
6.4
7.4
18
28
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.5
7.3
243
1653
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
1.6
7.3
166
1032
ND2DA
NOMESCO Finland
Bilateral hand X-ray examination
2.1
7.3
75
356
JG1JB
NOMESCO Finland
Defekography with X-ray
3.3
7.3
34
103
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.2
7.3
857
7125
NB1BG
NOMESCO Finland
Shoulder and humerus MRI examination with high intensity magnet
2.1
7.3
81
396
S01GX02
ATC
levocabastine; ophthalmic
1.5
7.3
212
1400
L04
ICPC
Chest symptom/complaint
1.6
7.3
181
1151
SCA01
NOMESCO Finland
Simple analysis and advice of nutrition with regard to dentistry
1.2
7.3
1037
8806
J01EA01
ATC
trimethoprim; systemic
1.3
7.2
810
6691
GD2SN
NOMESCO Finland
Lung ventilation SPECT
3.5
7.2
31
88
NH3DA
NOMESCO Finland
Bilateral foot X-ray examination
2.1
7.2
81
398
H65.9
ICD-10 Finland
Nonsuppurative otitis media, unspecified
3.6
7.2
30
83
M79.7
ICD-10 Finland
Fibromyalgia
1.8
7.2
121
688
AA4CG
NOMESCO Finland
Extensive MRI examination of sella turcica with high intensity magnet
2.8
7.2
43
155
WX100
NOMESCO Finland
Conjunctival surface anesthesia
1.5
7.2
275
1929
J01XB01
ATC
colistin; inhalant, parenteral
30.0
7.1
9
*
N81.6
ICD-10 Finland
Rectocele
1.6
7.1
186
1196
R03BC01
ATC
cromoglicic acid; inhalant
2.4
7.1
55
229
NBG00
NOMESCO Finland
Plastic operation on acromioclavicular joint
2.3
7.1
65
291
ZXD10
NOMESCO Finland
Scheduled procedure
1.2
7.1
1399
12265
4211
FHL
Transeptal septal resection and reconstruction
2.8
7.0
43
157
ZXC35
NOMESCO Finland
Use of radio waves
5.6
7.0
19
34
SPAT1059
SPAT
Spirometry at the office
1.6
7.0
171
1082
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.4
7.0
395
2966
50499
ICD-8 Finland
Deflected nasal septum
2.4
7.0
57
243
Z3232
NOMESCO Finland
Midwife
0.6
7.0
109
1771
N02CC04
ATC
rizatriptan; oral
1.5
7.0
206
1364
EMA30
NOMESCO Finland
Biopsy of rhinopharynx
7.0
7.0
16
23
NA1BA
NOMESCO Finland
Cervical spine extensive X-ray examination without contrast
2.9
6.9
40
139
SPAT1377
SPAT
Polysomnography
1.7
6.9
121
699
J02.9
ICD-10 Finland
Acute pharyngitis, unspecified
1.6
6.9
157
977
ZXC10
NOMESCO Finland
Use of laser
2.0
6.9
83
419
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
1.8
6.9
119
685
WZC05
NOMESCO Finland
Specialty-specific consultation based on referral by dentist or doctor
1.6
6.9
179
1152
T78.2
ICD-10 Finland
Anaphylactic shock, unspecified
2.7
6.9
45
170
F60.5
ICD-10 Finland
Anankastic personality disorder
2.7
6.9
45
170
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
1.6
6.9
153
945
KC1EE
NOMESCO Finland
Ultrasound measurement of residual urine
1.4
6.9
394
2970
DEB10
NOMESCO Finland
Attico-antro-mastoidectomy
13.8
6.9
11
8
H10.3
ICD-10 Finland
Acute conjunctivitis, unspecified
1.6
6.9
191
1249
H66.4
ICD-10 Finland
Suppurative otitis media, unspecified
3.5
6.9
30
87
K03.66
ICD-10 Finland
Tooth plaque
1.5
6.9
206
1370
SPAT1281
SPAT
Other administrative function
1.4
6.9
267
1877
ZSN00
NOMESCO Finland
Procedure related to previous procedure classified in chapter N
3.7
6.8
28
77
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.3
6.8
428
3271
N06AA10
ATC
nortriptyline; systemic
2.0
6.8
80
401
R09.3
ICD-10 Finland
Abnormal sputum
3.3
6.8
31
93
WX702
NOMESCO Finland
Supraglottic ventilation device
1.5
6.8
190
1248
DM1AA
SPAT
NA
3.5
6.8
29
83
N03AX11
ATC
topiramate; oral
1.9
6.8
95
512
DMB35
NOMESCO Finland
Endoscopic excision of neoplasm or another lesion from maxillary sinus
40.1
6.8
8
*
DH_2
NOMESCO Finland
Endoscopy of nose
40.1
6.8
8
*
DM1BG
NOMESCO Finland
Paranasal sinuses and face area standard MRI examination with high intensity magnet
40.1
6.8
8
*
C10AC01
ATC
colestyramine; oral
1.9
6.8
88
458
SPAT1033
SPAT
Irrigation or wax removal of outer auditory canal
1.3
6.8
571
4557
N05BA12
ATC
alprazolam; oral
1.4
6.7
359
2672
NGF00
NOMESCO Finland
Excision of plica of synovy of knee
1.9
6.7
90
474
K10.3
ICD-10 Finland
Alveolitis of jaws
1.6
6.7
156
976
A07EC02
ATC
mesalazine; oral, rectal
1.5
6.7
201
1338
N76.0
ICD-10 Finland
Acute vaginitis
1.6
6.7
178
1153
EB1JA
NOMESCO Finland
Double panorama tomography of teeth and jaws or similar X-ray examination
3.1
6.7
34
111
J05AH02
ATC
oseltamivir; oral
3.2
6.7
32
100
LWC00
NOMESCO Finland
Reoperation for deep infection in gynaecological surgery
22.5
6.7
9
*
M95.0
ICD-10 Finland
Acquired deformity of nose
3.3
6.6
31
95
L50.0
ICD-10 Finland
Allergic urticaria
1.9
6.6
85
440
AB5BT
NOMESCO Finland
Blockage of nerv root with X-ray guidance
2.9
6.6
36
123
J35.1
ICD-10 Finland
Hypertrophy of tonsils
2.2
6.6
59
264
G04CA02
ATC
tamsulosin; oral
1.3
6.6
641
5204
Z2446
NOMESCO Finland
Social worker
0.6
6.6
84
1428
LCA13
NOMESCO Finland
Curettage of cervix and body of uterus
1.6
6.6
169
1086
M76.0
ICD-10 Finland
Gluteal tendinitis
2.2
6.6
64
297
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.3
6.6
455
3529
GCA98
NOMESCO Finland
Other bronchoscopic procedure on bronchus
3.2
6.6
31
96
S81.8
ICD-10 Finland
Open wound of other parts of lower leg
1.8
6.6
97
532
SFC00
NOMESCO Finland
Pillar of fillings material
1.8
6.5
99
548
R07.0
ICD-10 Finland
Pain in throat
1.5
6.5
214
1454
D80.0
ICD-10 Finland
Hereditary hypogammaglobulinaemia
10.0
6.5
12
12
SAD02
NOMESCO Finland
Assessment of need for oral health care, extensive
1.7
6.5
136
830
46104
ICD-8 Finland
Acute sinusitis, Pansinuitis
6.2
6.5
16
26
NA3EA
NOMESCO Finland
Lumbar spine X-ray examination with flexion
1.8
6.5
98
542
NE1CG
NOMESCO Finland
Pelvic, hip and femur extensive MRI examination with high intensity magnet
2.0
6.4
77
388
N71.0
ICD-10 Finland
Acute inflammatory disease of uterus
1.9
6.4
84
441
M65.3
ICD-10 Finland
Trigger finger
1.6
6.4
140
862
WW200
SPAT
NA
0.7
6.4
209
2932
CAC20
NOMESCO Finland
Lateral decompression of orbit
14.3
6.4
10
7
NH1BG
NOMESCO Finland
Ankle and foot MRI examination with high intensity magnet
2.1
6.4
66
317
NG1CG
NOMESCO Finland
Knee and lower leg extensive MRI examination with high intensity magnet
2.0
6.4
75
379
N41.1
ICD-10 Finland
Chronic prostatitis
1.9
6.4
81
420
J04.0
ICD-10 Finland
Acute laryngitis
1.8
6.4
110
633
S83.2
ICD-10 Finland
Tear of meniscus, current
1.4
6.4
248
1749
-56
ICPC
Dressing/pressure/compress/tamponade
2.3
6.4
55
243
H93.1
ICD-10 Finland
Tinnitus
1.5
6.3
216
1479
SPAT1057
SPAT
Peak expiratory flow measurement
2.0
6.3
72
358
K03.82
ICD-10 Finland
Split tooth for reasons other than trauma
1.4
6.3
260
1852
C07AA05
ATC
propranolol; systemic
1.2
6.3
695
5726
M05BA04
ATC
alendronic acid; oral
1.5
6.3
198
1334
SDA01
NOMESCO Finland
Simple parodonthologic therapy
1.2
6.3
919
7812
C05AA01
ATC
hydrocortisone; rectal, topical
1.6
6.3
169
1098
WX110
SPAT
NA
0.5
6.3
57
1062
R49.01
ICD-10 Finland
Functional dysphonia
1.8
6.3
98
546
R05CB02
ATC
bromhexine; systemic
2.5
6.3
45
181
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
1.5
6.2
172
1127
SPAT1229
SPAT
Assessment of need for aid
1.5
6.2
212
1452
H00.03
ICD-10 Finland
Preseptal cellulite in the eyelid
4.3
6.2
21
49
N07CA01
ATC
betahistine; oral
1.5
6.2
223
1546
SCA03
NOMESCO Finland
Preventive oral health care, extensive
1.6
6.2
154
984
ZXX01
NOMESCO Finland
Extent of proceudre, 1 unit
2.8
6.2
36
128
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
1.3
6.1
390
2989
K23.8*B37.8
ICD-10 Finland
Esophagitis caused by candidiasis
4.5
6.1
20
45
N39.3
ICD-10 Finland
Stress incontinence
1.5
6.1
218
1509
H04.4
ICD-10 Finland
Chronic inflammation of lacrimal passages
5.7
6.1
16
28
R21
ICPC
Throat symptom/complaint
1.2
6.1
699
5784
Z03.3
ICD-10 Finland
Observation for suspected nervous system disorder
1.5
6.1
181
1206
S02.51
ICD-10 Finland
Fracture of tooth, open
1.4
6.1
348
2622
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
1.5
6.1
173
1138
NH3EA
NOMESCO Finland
Feet X-ray examination with load
1.9
6.1
77
400
XCC00
NOMESCO Finland
Investigative irrigation of lacrimal passages
2.6
6.1
41
160
JHB00
NOMESCO Finland
Hemorrhoidectomy
1.7
6.1
115
683
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
1.5
6.1
216
1497
S82
ICPC
Naevus/mole
1.3
6.1
395
3037
N04BC05
ATC
pramipexole; oral
1.5
6.1
217
1502
A01AB10
ATC
natamycin; local oral
1.9
6.0
87
474
N06CA01
ATC
amitriptyline and psycholeptics; systemic
1.4
6.0
321
2392
SPAT1336
SPAT
Request for examination
0.5
6.0
35
749
FM1TQ
NOMESCO Finland
Heart perfusion SPECT with low dose CT at rest and with exercise
4.9
6.0
18
37
4225
FHL
Exploratory buccal opening, includes polyps and cyst removal
4.4
6.0
20
46
G43.0
ICD-10 Finland
Migraine without aura [common migraine]
1.5
6.0
189
1275
GDA98
NOMESCO Finland
Other bronchoscopic incision, excision of lesion or repair of lung
3.3
6.0
27
81
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3005322) IgE [Units/volume] in Serum or Plasma
1137
2750
5.00
307.65
1.9
1.2
u/ml
280.1
203.7
1.31
1089
2554
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
273
283
10.12
236.69
1.5
1.3
u/ml
1.4
0.5
1.28
148
118
(3007853) Bacteria identified in Skin by Aerobe culture
1206
4910
2.89
204.30
2.3
1.7
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
250
454
5.73
131.50
1.7
1.4
g/l
0.4
0.4
1.36
181
310
(3028192) IgG subclass 2 [Mass/volume] in Serum
250
454
5.73
131.50
1.7
1.4
g/l
3.0
3.0
0.22
179
312
(3027135) IgG subclass 1 [Mass/volume] in Serum
250
455
5.72
131.19
1.7
1.4
g/l
6.4
6.7
0.54
181
312
(3042936) Bacteria identified in Isolate by Culture
1200
5903
2.34
130.85
2.4
2.1
—
—
—
0
0
(4062490)
246
455
5.62
126.85
1.7
1.4
—
—
—
0
0
(42870588) Differential panel, method unspecified - Blood
2273
14480
2.01
125.62
6.3
6.0
—
—
—
0
0
(4010399)
725
2943
2.70
118.44
1.7
1.4
—
—
—
0
0
(3010726) Horse dander IgE Ab [Units/volume] in Serum
309
738
4.39
117.77
1.2
1.1
u/ml
0.7
1.8
3.06
105
175
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
335
898
3.92
109.16
1.3
1.1
u/ml
0.5
1.5
2.38
186
338
(3013115) Eosinophils [#/volume] in Blood
3093
22525
1.91
108.99
6.5
6.2
e9/l
0.3
0.2
87.21
2826
19945
(3013512) EKG study
1877
11640
1.95
107.93
3.8
3.6
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
1019
5045
2.27
107.14
4.3
4.3
%
32.2
31.7
0.69
736
3553
(3003888) Timothy IgE Ab [Units/volume] in Serum
305
796
4.01
103.09
1.2
1.1
u/ml
2.4
5.3
4.49
188
402
(3002030) Lymphocytes/100 leukocytes in Blood
2910
21048
1.86
101.78
6.7
6.2
%
28.2
28.4
0.47
2719
19715
(3019069) Monocytes/100 leukocytes in Blood
2841
20420
1.85
101.13
6.9
6.4
%
8.2
8.5
7.32
2686
19226
(3006504) Eosinophils/100 leukocytes in Blood
2822
20306
1.84
99.43
6.6
6.1
%
4.0
2.8
72.58
2643
19007
(3014133) Dog dander IgE Ab [Units/volume] in Serum
267
653
4.25
98.47
1.2
1.0
u/ml
2.0
3.7
1.41
137
246
(3023419) Bacteria identified in Sputum by Culture
225
482
4.83
98.02
4.4
2.4
—
—
—
0
0
(3018010) Neutrophils/100 leukocytes in Blood
2860
20747
1.83
97.29
6.3
6.0
%
56.0
56.9
4.39
2688
19506
(3023430) Cat dander IgE Ab [Units/volume] in Serum
251
598
4.36
95.77
1.1
1.1
u/ml
2.2
4.1
1.34
125
229
(3024980) IgG subclass 4 [Mass/volume] in Serum
283
742
3.97
94.95
1.9
1.7
g/l
1.0
0.8
1.68
206
562
(3022096) Basophils/100 leukocytes in Blood
2736
19677
1.82
94.79
6.7
6.2
%
0.7
0.7
6.87
2571
18443
(3013707) Erythrocyte sedimentation rate by Westergren method
3978
32166
1.98
94.49
5.1
3.9
mm/h
10.8
11.1
0.91
3703
30033
(3006315) Basophils [#/volume] in Blood
2951
21796
1.81
92.70
6.4
6.0
e9/l
0.0
0.0
19.01
2692
18947
(3008401) Mugwort IgE Ab [Units/volume] in Serum
285
766
3.88
92.32
1.2
1.1
u/ml
0.8
1.1
0.35
153
308
(3001604) Monocytes [#/volume] in Blood
2930
21717
1.79
89.71
6.4
5.9
e9/l
0.6
0.6
1.67
2684
18887
(3019198) Lymphocytes [#/volume] in Blood
2998
22379
1.79
89.52
6.4
6.0
e9/l
2.0
1.9
0.23
2759
19862
(3019225) pH of Specimen
808
3908
2.26
88.45
3.9
4.1
—
—
—
0
0
(40768804) Tissue Pathology biopsy report
2496
17719
1.78
87.96
2.1
2.0
—
—
—
0
0
(3003284) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum by Immunofluorescence
405
1418
3.01
86.25
1.8
1.6
titre
132.6
424.6
1.85
19
57
(3000492) Spirometry study
861
4468
2.11
78.19
1.7
1.4
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
701
3363
2.25
77.59
3.3
2.7
g/l
10.1
10.6
2.13
646
3078
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
121
180
6.86
77.49
1.1
1.1
u/ml
5.0
5.7
0.12
29
32
(3028026) IgM [Mass/volume] in Serum or Plasma
581
2605
2.38
75.21
1.8
1.9
g/l
1.2
1.4
1.81
535
2403
(3009445) Proteinase 3 Ab [Units/volume] in Serum
440
1770
2.62
71.73
1.7
1.6
u/ml
6.3
15.6
1.36
13
46
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
204
541
3.88
67.20
1.1
1.0
u/ml
0.3
0.3
0.06
70
114
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
255
785
3.36
67.17
1.3
1.2
titre
60.0
282.7
—
7
15
(40761536) Microorganisms panel - Urine sediment
709
3607
2.12
67.10
3.8
3.7
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
2109
15244
1.64
62.37
3.7
3.3
ng/l
30.3
79.8
0.87
1318
9614
(3036481) Cortisol [Moles/volume] in Serum or Plasma
749
4009
2.01
61.40
2.6
2.2
nmol/l
327.2
368.9
5.63
700
3706
(3032080) INR in Blood by Coagulation assay
2193
16150
1.61
59.18
7.7
8.2
inr
1.2
1.2
2.62
737
4764
(3013650) Neutrophils [#/volume] in Blood by Automated count
3124
25060
1.61
58.73
8.3
9.3
e9/l
4.1
4.0
0.76
2858
21985
(3000494) Fungus identified in Specimen by Culture
877
5160
1.84
53.48
1.9
1.4
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
4837
44194
2.21
52.53
15.8
13.0
mg/l
19.0
22.7
14.55
4097
34714
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
206
647
3.27
52.47
1.8
1.4
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
1474
10084
1.64
52.09
5.1
4.4
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
3036
24641
1.55
50.50
4.3
4.7
mmol/l
6.5
6.7
5.62
2854
22992
(4015189)
69
90
7.76
49.68
2.9
2.2
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1828
13301
1.57
49.39
2.7
2.6
u/l
55.9
57.8
0.64
1658
12347
(3018993) Complement total hemolytic CH100 [Units/volume] in Serum or Plasma
64
78
8.29
48.75
1.1
1.2
—
—
—
0
0
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
726
4173
1.86
47.26
3.3
3.2
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
363
1621
2.33
46.76
2.1
1.9
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
3471
29315
1.54
45.80
4.6
4.0
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
467
2335
2.10
45.46
3.3
3.4
mmol/l
1.3
1.7
1.54
355
1734
(3009343) pH of Capillary blood
480
2425
2.08
45.45
3.4
3.4
ph
7.4
7.4
0.67
76
299
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
484
2459
2.07
45.13
3.4
3.4
kpa
5.1
5.2
0.16
442
2289
(3042631) Mycobacterium sp identified in Specimen
166
506
3.36
44.37
3.8
2.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
332
1474
2.34
43.29
1.9
1.8
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
3532
30136
1.53
42.76
3.6
3.1
—
—
—
0
0
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
3810
33073
1.56
42.38
8.0
7.6
u/l
75.5
76.8
0.85
3580
31307
(3022145) Colonoscopy Study observation
792
4818
1.76
42.35
1.4
1.3
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
1598
11594
1.54
42.18
3.1
3.0
—
—
—
0
0
(3007164) IgA [Mass/volume] in Serum or Plasma
1257
8639
1.60
42.05
1.6
1.5
g/l
2.3
2.4
1.32
879
5464
(3002179) Metamyelocytes/100 leukocytes in Blood
589
3303
1.88
41.10
3.7
4.0
%
0.6
0.6
0.05
150
736
(3017732) Neutrophils [#/volume] in Blood
559
3083
1.91
41.05
2.6
2.8
e9/l
4.0
4.1
0.30
420
2498
(44813793)
116
293
4.03
40.92
1.1
1.1
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
334
1532
2.26
40.30
3.6
3.6
mmol/l
24.8
24.8
0.01
309
1428
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
81
156
5.26
39.92
5.5
4.1
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
601
3431
1.85
39.57
3.8
4.3
%
0.1
0.2
0.32
182
942
(40768797) Stomach Pathology biopsy report
926
5987
1.66
39.32
1.3
1.2
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
142
429
3.37
38.52
2.2
2.5
e9/l
1.4
1.2
2.05
76
264
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
287
1262
2.35
38.21
3.1
2.7
—
—
—
0
0
(3025271) CD3-CD16+CD56+ (Natural killer) cells [#/volume] in Blood
110
282
3.96
38.03
2.3
2.7
e9/l
0.2
0.2
0.43
92
249
(3037522) Nuclear Ab [Titer] in Serum
948
6237
1.63
37.39
1.4
1.4
titre
470.1
541.4
0.52
190
1274
(3017181) Myelocytes/100 leukocytes in Blood
613
3606
1.79
36.43
3.8
4.2
%
0.8
0.9
0.47
185
1017
(3001405) CD3+CD8+ (T8 suppressor) cells [#/volume] in Blood
110
291
3.84
36.41
2.3
2.6
e6/l
510.9
542.1
0.24
91
250
(3022313) Gas panel - Capillary blood
360
1774
2.11
36.22
3.5
3.5
—
—
—
0
0
(3025159) Blasts/100 leukocytes in Blood
560
3242
1.81
35.03
3.8
4.3
%
0.0
0.3
1.17
158
785
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
3832
33803
1.50
34.96
4.5
3.9
pmol/l
14.7
14.7
1.41
3455
31153
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
47
59
8.03
34.94
1.2
1.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
2489
20266
1.43
34.80
4.0
4.0
—
—
—
0
0
(3027300) Silver Birch IgE Ab [Units/volume] in Serum
69
132
5.28
34.29
1.1
1.0
u/ml
2.5
5.0
1.02
14
17
(3048689) Calprotectin [Mass/mass] in Stool
842
5485
1.64
34.27
2.7
2.4
ug/g
145.5
130.4
0.49
641
4397
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
934
6266
1.60
33.63
2.1
1.8
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
139
453
3.12
33.34
2.2
2.2
mg/l
21.7
22.0
0.02
43
121
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
4416
40304
1.60
33.18
5.4
4.6
mu/l
1.8
2.0
2.41
4022
37391
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
3549
30968
1.45
33.12
3.4
3.1
u/l
45.7
47.2
0.45
3276
29227
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
2648
21936
1.42
32.88
5.8
6.3
umol/l
10.4
11.2
2.74
2455
20868
(3031040) Bacteria [#/volume] in Urine by Automated count
3208
27515
1.43
32.60
4.5
4.1
e6/l
36.2
1521.0
4.46
65
363
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
1059
7387
1.54
31.97
1.3
1.3
u/ml
10.3
10.6
0.06
380
3016
(3001122) Ferritin [Mass/volume] in Serum or Plasma
2330
18948
1.41
31.72
3.0
2.8
ug/l
119.6
124.5
0.49
2120
17746
(3003338) MCHC [Mass/volume]
3468
38673
0.70
31.55
17.0
16.5
g/l
333.2
333.1
0.31
3455
38431
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
1100
7766
1.53
31.34
1.3
1.3
iu/ml
24.2
30.9
1.26
310
2455
(3023103) Potassium [Moles/volume] in Serum or Plasma
4817
45112
1.83
31.24
15.9
14.6
mmol/l
4.0
4.0
1.13
4690
43984
(3019550) Sodium [Moles/volume] in Serum or Plasma
4800
44942
1.80
30.64
15.9
14.5
mmol/l
139.7
139.7
0.10
4675
43898
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
2246
18253
1.40
30.17
5.2
6.1
mmol/l
1.2
1.2
8.77
1964
16673
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
2154
17411
1.40
29.71
2.5
2.2
nmol/l
78.1
76.1
2.68
1914
15929
(3019309) Folate [Moles/volume] in Red Blood Cells
984
6875
1.53
29.17
2.0
1.7
nmol/l
1182.2
1157.7
0.35
730
5323
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
141
504
2.85
28.76
1.5
1.4
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
141
505
2.84
28.66
1.5
1.4
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
142
511
2.83
28.61
1.5
1.4
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
140
502
2.84
28.40
1.5
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
143
519
2.80
28.36
1.5
1.4
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
141
514
2.79
27.74
1.5
1.4
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
1605
12499
1.41
26.75
2.3
2.1
u/l
148.2
221.3
4.96
1496
11810
(40761511) CBC panel - Blood by Automated count
4903
46445
1.85
26.68
15.5
12.1
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
4368
40250
1.51
26.30
5.7
5.3
mmol/mol
39.3
39.3
0.19
4013
37733
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
1164
8572
1.46
26.30
1.8
1.6
pmol/l
7143308.6
32482577.9
2.10
938
7284
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
105
337
3.16
25.91
1.8
2.2
%
12.1
14.4
1.12
55
143
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
1286
9677
1.44
25.82
1.7
1.7
mg/l
0.9
1.1
1.39
933
7343
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
1296
9769
1.43
25.77
1.3
1.3
u/ml
1.8
1.9
0.07
359
2708
(3012110) Lysozyme [Mass/volume] in Serum or Plasma
243
1194
2.09
24.58
2.4
2.0
mg/l
9.3
11.1
3.13
227
1118
(3012501) Base excess in Blood by calculation
201
925
2.22
24.03
4.2
4.2
mmol/l
2.1
2.5
1.52
141
628
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
251
1267
2.03
23.61
1.3
1.4
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
337
1900
1.83
22.76
2.5
1.9
u/l
40.0
39.3
0.29
313
1711
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
2383
20128
1.34
22.71
6.1
6.9
mmol/l
1.2
1.2
6.77
1833
17114
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
196
918
2.18
22.45
1.4
1.4
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
5129
49640
2.49
22.16
22.8
19.1
e9/l
260.6
253.1
14.21
5041
48542
(3023368) Bacteria identified in Blood by Culture
1365
10626
1.38
21.92
4.1
4.4
—
—
—
0
0
(3010421) pH of Blood
220
1088
2.07
21.89
4.0
4.1
ph
7.4
7.4
0.08
199
910
(3008757) Leukocyte morphology finding [Identifier] in Blood
111
405
2.78
21.87
3.5
4.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
134
538
2.53
21.83
1.4
1.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
5128
49672
2.44
21.29
22.6
19.0
pg
30.3
30.3
1.16
5061
49087
(3024731) MCV [Entitic volume]
5128
49672
2.44
21.29
22.6
19.0
fl
90.8
90.8
0.03
5061
49089
(3010813) Leukocytes [#/volume] in Blood
5129
49691
2.44
21.20
22.8
19.1
e9/l
6.9
6.7
14.99
5031
48466
(3013005) Retinol [Moles/volume] in Serum or Plasma
67
184
3.68
21.15
2.5
1.7
umol/l
1.8
2.0
1.13
61
172
(3026361) Erythrocytes [#/volume] in Blood
5128
49680
2.43
21.14
22.7
19.1
e12/l
4.6
4.5
1.79
5028
48469
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
1972
16318
1.33
21.14
3.6
3.5
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
5128
49690
2.42
20.96
22.9
19.2
g/l
137.3
137.0
1.26
5062
49098
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
164
736
2.27
20.87
1.6
1.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
186
879
2.16
20.85
3.9
3.6
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
135
557
2.46
20.78
1.5
1.4
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
204
1007
2.07
20.41
1.8
1.6
—
—
—
0
0
(36203821) Streptococcus pneumoniae Danish serotype 1 IgG Ab [Mass/volume] in Serum
25
28
8.97
20.30
1.6
1.6
mg/l
3.0
1.6
0.40
14
20
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
147
639
2.34
20.16
1.5
1.4
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
137
580
2.40
19.95
1.6
1.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
160
727
2.24
19.78
1.9
1.7
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
502
3283
1.59
19.47
3.9
4.0
mmol/l
1.2
1.2
0.24
428
2882
(3025941) Bacteria identified in Stool by Culture
408
2536
1.66
19.46
1.3
1.2
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
1309
10284
1.36
19.45
2.3
2.3
—
—
—
0
0
(3005665) Streptococcus pneumoniae Danish serotype 6B IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
2.1
1.4
0.20
12
22
(36203922) Streptococcus pneumoniae Danish serotype 14 IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
4.3
4.7
0.07
15
19
(36204005) Streptococcus pneumoniae Danish serotype 19F IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
1.5
1.9
0.29
15
16
(3000899) Streptococcus pneumoniae Danish serotype 7F IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
3.3
3.1
0.04
15
21
(36204187) Streptococcus pneumoniae Danish serotype 4 IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
1.3
0.9
0.12
16
20
(3006665) Streptococcus pneumoniae Danish serotype 18C IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
1.6
2.0
0.16
16
20
(36204094) Streptococcus pneumoniae Danish serotype 23F IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
5.0
2.2
0.63
16
19
(36204286) Streptococcus pneumoniae Danish serotype 5 IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
3.1
1.5
—
10
19
(3005260) Streptococcus pneumoniae Danish serotype 9V IgG Ab [Mass/volume] in Serum
24
27
8.93
19.42
1.6
1.6
mg/l
0.9
0.6
0.29
14
18
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
4947
47452
1.75
19.32
11.4
10.0
u/l
27.0
27.4
0.80
4761
46019
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
92
325
2.86
19.29
2.0
2.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
59
159
3.74
19.17
1.9
2.2
%
12.1
8.7
1.13
54
146
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
26
33
7.91
19.14
1.1
1.2
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
1315
10372
1.36
18.97
2.8
2.9
ng/l
825.6
1198.8
3.78
1055
8752
(3024561) Albumin [Mass/volume] in Serum or Plasma
2097
17695
1.31
18.91
4.5
5.0
g/l
35.7
35.9
0.88
1918
16542
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
228
1208
1.93
18.70
1.2
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
1280
10083
1.36
18.55
2.5
2.2
mg/l
2.8
2.9
0.10
1103
8684
(3029937) Albumin [Presence] in Urine by Test strip
1390
11109
1.34
18.26
3.8
3.8
estimate
0.0
0.0
0.35
646
3798
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
68
208
3.30
18.26
2.0
1.9
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
68
208
3.30
18.26
2.0
1.9
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
68
208
3.30
18.26
2.0
1.9
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
68
208
3.30
18.26
2.0
1.9
—
—
—
0
0
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
58
160
3.65
18.23
2.1
2.1
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
52
134
3.91
18.01
2.8
3.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
194
988
2.00
17.85
1.9
1.6
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
57
158
3.64
17.80
2.1
2.1
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
57
158
3.64
17.80
2.1
2.1
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
102
400
2.58
17.52
2.6
3.5
%
57.7
57.0
0.12
74
250
(40767503) Oxygen content in Capillary blood by calculation
173
851
2.07
17.52
2.7
2.4
%
17.2
16.4
1.65
92
417
(40766189) Gliadin peptide IgG Ab [Units/volume] in Serum by Immunoassay
226
1228
1.88
17.18
1.1
1.1
u/ml
4.6
5.8
0.13
20
165
(3002256) Pathology report gross observation
765
5601
1.43
17.05
1.2
1.3
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
219
1202
1.86
16.15
2.1
1.8
—
—
—
0
0
(3017766) Complement C4 [Mass/volume] in Serum or Plasma
239
1352
1.80
15.99
1.5
1.7
g/l
0.2
0.2
0.42
231
1280
(21494815) CD4 cells/100 lymphocytes in Specimen
95
383
2.51
15.46
1.9
2.4
%
39.9
42.9
0.28
17
49
(3000620) Complement C3 [Mass/volume] in Serum or Plasma
243
1406
1.76
15.07
1.5
1.7
g/l
1.2
1.2
0.30
234
1332
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
146
717
2.07
14.90
1.4
1.4
u/l
24.8
26.7
0.28
118
591
(3004809) Band form neutrophils/100 leukocytes in Blood
137
659
2.11
14.77
2.7
3.4
%
0.9
1.5
1.88
106
506
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
4645
44272
1.43
14.76
4.7
4.2
mmol/l
4.8
4.7
3.73
4235
41645
(3011397) Hemoglobin [Presence] in Urine by Test strip
742
9751
0.72
14.68
3.7
3.4
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
87
345
2.55
14.67
1.2
1.2
u/ml
72.4
45.6
—
5
30
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
4489
42556
1.38
14.55
4.2
3.8
mmol/l
1.3
1.3
0.21
4065
39638
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
143
705
2.06
14.45
1.1
1.1
au/ml
8.2
11.7
—
7
48
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
4620
44022
1.41
14.41
4.7
4.2
mmol/l
1.5
1.5
2.05
4198
41229
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
89
362
2.48
14.25
1.8
1.7
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
89
362
2.48
14.25
1.8
1.7
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
89
362
2.48
14.25
1.8
1.7
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
649
4766
1.41
14.06
1.4
1.4
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
4694
44890
1.43
14.00
5.0
4.6
mmol/l
2.9
2.8
1.05
4259
41965
(3047007) Chlamydophila sp Ab [Presence] in Serum
132
644
2.08
13.74
1.2
1.2
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
65
231
2.84
13.60
1.7
1.6
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
1606
13516
1.27
13.53
2.3
2.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
420
2862
1.51
13.44
1.7
1.7
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
4416
41879
1.34
13.26
12.8
11.9
ml/min/173m2
85.1
84.5
1.28
3869
34673
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
109
504
2.19
13.04
1.1
1.1
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
133
664
2.03
13.03
1.1
1.1
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
64
231
2.79
13.02
1.7
1.6
—
—
—
0
0
(40768443) Skin Pathology biopsy report
288
1818
1.62
12.92
1.2
1.2
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
4482
42649
1.35
12.76
4.8
4.3
mmol/l
5.8
5.9
2.53
4028
39477
(3009261) Glucose [Presence] in Urine by Test strip
2393
21193
1.24
12.59
3.5
3.4
estimate
0.0
0.0
0.58
637
3799
(3003327) Ova and parasites identified in Stool by Light microscopy
244
1489
1.67
12.52
2.1
1.7
—
—
—
0
0
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
77
314
2.47
12.31
2.5
2.6
e6/l
722.3
690.2
0.19
51
131
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
1052
8477
1.30
12.30
1.6
1.5
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
45
137
3.30
12.28
1.3
1.2
—
—
—
0
0
(3000570) Elastase.pancreatic [Mass/mass] in Stool
206
1207
1.74
12.28
1.4
1.4
ug/g
301.1
281.4
0.63
109
685
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
477
6535
0.70
11.87
2.8
2.8
e6/l
1.9
2.5
1.96
260
3477
(3035350) Ketones [Presence] in Urine by Test strip
2354
20924
1.23
11.61
3.4
3.4
estimate
0.0
0.0
1.08
649
3830
(3021601) Nitrite [Presence] in Urine by Test strip
2358
20970
1.23
11.55
4.5
4.6
estimate
0.0
0.0
0.39
658
3942
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
67
264
2.56
11.53
1.7
1.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
94
431
2.20
11.53
2.1
1.7
—
—
—
0
0
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1878
16318
1.24
11.47
2.0
1.9
pmol/l
101.5
96.2
4.07
1018
8670
(3045424) Erythrocytes [Presence] in Urine
137
725
1.91
11.41
1.3
1.5
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
1976
17316
1.23
10.99
2.9
2.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
75
319
2.37
10.99
1.7
1.6
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
1086
8918
1.27
10.78
1.6
1.5
nmol/l
20.0
20.4
0.43
890
7719
(3014373) Corynebacterium diphtheriae Ab [Units/volume] in Serum
18
29
6.22
10.72
1.2
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
69
286
2.43
10.71
1.6
1.2
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
195
1175
1.69
10.54
1.2
1.3
u/ml
4.2
5.5
0.17
15
120
(3023520) Reticulocytes [#/volume] in Blood
431
3095
1.43
10.53
2.8
2.6
e9/l
68.5
70.3
0.59
345
2329
(3015377) Calcium [Moles/volume] in Serum or Plasma
1589
13659
1.23
10.52
2.7
3.4
mmol/l
2.3
2.4
1.90
1344
12129
(3015235) Bicarbonate [Moles/volume] in Capillary blood
167
965
1.75
10.50
2.7
3.2
mmol/l
24.7
24.8
0.20
148
841
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
97
468
2.09
10.50
2.1
1.7
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
69
290
2.40
10.40
1.6
1.2
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
224
1407
1.62
10.31
1.7
1.9
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
533
7005
0.73
10.16
2.6
2.6
e6/l
0.8
1.1
1.02
318
3921
(3002670) Multiple inhalant allergen IgE Ab [Units/volume] in Serum
54
204
2.66
10.16
1.6
1.9
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
397
2827
1.44
10.15
3.5
3.4
pmol/l
4.5
4.5
0.05
352
2542
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
260
1699
1.56
10.12
2.2
2.2
u/l
5941.3
5046.6
0.17
85
673
(3000060) B lymphocytes [#/volume] in Blood
37
113
3.29
10.10
1.6
2.2
e6/l
238.6
167.8
0.70
14
60
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
195
1189
1.66
10.10
1.2
1.3
u/ml
2.2
8.5
2.97
27
188
(3037692) Legionella sp identified in Specimen by Organism specific culture
43
144
3.00
10.09
1.7
1.4
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
30
926
0.32
9.81
5.9
3.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
489
3633
1.38
9.80
2.4
2.2
nmol/l
13.3
13.1
0.23
419
3251
(3047181) Lactate [Moles/volume] in Blood
207
1292
1.63
9.79
3.7
6.9
mmol/l
1.3
1.3
0.23
181
1133
(3003740) Influenza virus B Ag [Presence] in Specimen
138
772
1.81
9.71
1.1
1.1
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
206
1287
1.63
9.71
1.2
1.3
u/ml
79.0
39.1
—
6
83
(3002523) Influenza virus A Ag [Presence] in Specimen
138
773
1.81
9.67
1.1
1.1
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
219
1393
1.60
9.59
1.9
1.6
iu/ml
0.2
5.1
0.59
32
281
(3026285) Alpha 1 antitrypsin [Mass/volume] in Serum or Plasma
115
611
1.90
9.53
1.1
1.1
g/l
1.4
1.5
1.47
102
552
(3026493) Urate [Moles/volume] in Serum or Plasma
1342
11434
1.23
9.47
2.5
2.5
umol/l
602.5
4013.9
13.27
1144
10091
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
77
354
2.19
9.46
6.0
3.6
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
468
3472
1.38
9.46
1.2
1.2
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
148
853
1.76
9.43
2.2
2.1
g/l
134.0
130.4
1.03
114
613
(3027945) Reticulocytes/100 erythrocytes in Blood
556
4243
1.35
9.39
2.5
2.6
%
1.7
1.8
0.79
478
3799
(3032057) Clostridioides difficile [Presence] in Stool
26
66
3.95
9.30
1.7
2.0
—
—
—
0
0
(3015171) Extractable nuclear Ab [Units/volume] in Serum
266
1781
1.52
9.29
1.2
1.3
u/ml
0.7
1.1
0.55
23
157
(3026389) Candida sp identified in Specimen by Organism specific culture
109
575
1.91
9.24
1.4
1.3
—
—
—
0
0
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
289
4140
0.68
9.12
2.5
2.5
u/l
35.1
49.2
0.63
242
3582
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
253
1697
1.52
8.78
1.5
1.7
—
—
—
0
0
(3012494) Peanut IgE Ab [Units/volume] in Serum
34
109
3.13
8.63
1.1
1.1
u/ml
0.3
1.5
0.77
19
54
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
64
284
2.27
8.60
1.2
1.2
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
91
464
1.98
8.55
1.9
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
107
578
1.87
8.47
1.8
1.6
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
113
1974
0.56
8.47
3.6
3.1
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
122
687
1.79
8.46
2.5
2.7
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
426
3170
1.37
8.46
1.2
1.2
iu/ml
129.5
154.3
0.73
175
1180
(3028626) Oxygen [Partial pressure] in Capillary blood
141
829
1.72
8.42
3.6
2.8
kpa
8.7
8.1
3.16
125
760
(3036086) Jo-1 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
156
945
1.67
8.35
1.2
1.2
—
9.5
—
0
12
(3012095) Magnesium [Moles/volume] in Serum or Plasma
824
6736
1.26
8.30
3.5
3.5
mmol/l
0.8
0.8
1.97
763
6340
(3008898) HLA-B27 [Presence]
247
1672
1.50
8.23
1.1
1.1
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
1591
13963
1.20
8.07
5.2
4.4
ug/l
2.1
2.4
1.13
1414
12688
(3008536) Aspergillus sp Ab [Presence] in Serum
28
83
3.39
8.06
1.5
2.3
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
55
237
2.33
7.93
1.3
1.5
ug/l
8.6
8.0
0.10
45
211
(21494814) CD8 cells/100 lymphocytes in Specimen
47
189
2.50
7.88
1.8
2.1
—
—
—
0
0
(3020961) Endomysium IgA Ab [Titer] in Serum
299
2137
1.42
7.54
1.1
1.1
titre
74.0
178.0
—
5
62
(3004588) Protein electrophoresis panel - Serum or Plasma
353
2598
1.38
7.51
1.9
2.3
—
—
—
0
0
(3016244) Insulin [Units/volume] in Serum or Plasma
59
269
2.21
7.48
5.3
3.4
mu/l
31.4
27.0
0.33
59
258
(3016228) CD19 cells/100 cells in Blood
47
194
2.44
7.47
1.8
2.1
%
9.0
8.6
0.06
47
189
(3004789) Transferrin [Mass/volume] in Serum or Plasma
719
5868
1.26
7.30
2.2
2.5
g/l
2.4
2.3
2.92
649
5475
(3033658) Prothrombin time (PT) actual/Normal
933
11009
0.81
7.27
3.4
4.0
%
94.4
92.0
2.51
899
10741
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
151
945
1.62
7.17
1.2
1.2
u/ml
1.3
3.2
—
9
71
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
10
13
7.71
7.12
1.1
1.0
—
—
—
0
0
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
86
460
1.88
7.09
1.2
1.2
—
—
—
0
0
(3022948) Iron [Moles/volume] in Serum or Plasma
771
6364
1.25
7.08
2.2
2.5
umol/l
40.8
13.7
0.49
697
5939
(3015183) Erythrocyte sedimentation rate
55
251
2.20
6.98
1.1
1.2
—
—
—
0
0
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
39
153
2.56
6.92
2.1
1.8
u/ml
1207.5
23995.0
—
8
21
(43533860) Galactose-alpha-1,3-galactose (Alpha-Gal) IgE Ab [Units/volume] in Serum
19
48
3.97
6.88
1.2
1.1
u/ml
0.5
0.0
—
9
31
(3024354) Oxygen [Partial pressure] in Venous blood
202
2927
0.68
6.80
3.0
3.2
kpa
4.7
4.7
0.11
196
2829
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
497
3922
1.30
6.61
2.4
2.3
g/l
0.2
0.2
0.06
469
3680
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
50
225
2.23
6.59
1.7
1.3
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
3544
37227
0.85
6.58
16.3
15.8
%
13.6
13.6
0.10
3484
36465
(3036670) Protein [Mass/volume] in Synovial fluid
29
100
2.91
6.57
1.3
1.2
g/l
40.9
38.3
0.29
11
61
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
51
232
2.21
6.55
1.7
1.3
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
393
5076
0.76
6.53
6.5
7.4
mmol/l
104.8
104.5
0.93
377
4968
(3013139) Helicobacter pylori Ag [Presence] in Stool
385
2939
1.33
6.51
1.2
1.3
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
134
843
1.61
6.28
1.5
1.5
—
—
—
0
0
(3008832) Norclozapine [Moles/volume] in Serum or Plasma
7
318
0.22
6.27
13.9
13.2
nmol/l
507.3
845.7
—
7
304
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
87
487
1.80
6.26
1.6
1.6
%
52.8
57.2
0.39
55
304
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
379
2905
1.33
6.24
1.3
1.3
au/ml
48.1
50.9
0.07
15
131
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
99
577
1.73
6.21
1.4
1.6
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
43
911
0.47
6.04
1.4
1.4
—
—
—
0
0
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
19
53
3.59
6.03
1.0
1.1
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
63
324
1.96
5.90
1.9
1.2
—
—
—
0
0
(3043238) Trisomy 21 risk [Likelihood] in Fetus
46
937
0.49
5.79
1.4
1.5
—
—
—
0
0
(3009214) Lutropin [Units/volume] in Serum or Plasma
195
1356
1.45
5.78
1.4
1.4
u/l
10.8
9.5
0.60
164
1120
(3005033) Fetal Nuchal fold Thickness US
44
908
0.48
5.76
1.4
1.4
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
28
103
2.73
5.68
1.3
1.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
61
315
1.95
5.66
2.0
1.6
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
52
254
2.06
5.63
1.2
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
997
8628
1.19
5.63
2.7
2.5
e6/l
5.6
5.7
0.09
897
7556
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
217
1548
1.42
5.61
1.9
2.0
ug/l
2.3
2.3
0.01
184
1408
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
656
5453
1.23
5.61
2.3
2.6
%
23.1
23.6
0.45
537
4713
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
609
5024
1.24
5.59
5.9
6.3
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
92
1508
0.60
5.52
1.3
1.3
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
68
369
1.85
5.46
2.0
2.0
nmol/l
20.5
18.6
1.12
62
348
(3044927) Protein electrophoresis panel - Urine
67
365
1.85
5.32
1.2
1.2
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
22
74
2.98
5.25
1.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
22
74
2.98
5.25
1.0
1.2
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
22
74
2.98
5.25
1.0
1.2
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
24
85
2.83
5.23
1.2
1.4
—
—
—
0
0
(3008295) Osmolality of Serum or Plasma
76
433
1.77
5.22
1.3
1.4
mosm/kgh2o
279.5
280.6
0.18
65
340
(36032269) Testosterone Free [Moles/volume] in Serum or Plasma by calculation
163
1118
1.47
5.22
2.0
1.9
pmol/l
205.6
200.0
0.25
157
1058
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
51
255
2.01
5.21
1.4
1.3
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
166
1145
1.46
5.17
1.1
1.1
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
386
3047
1.29
5.16
2.7
2.8
ng/l
105.8
162.2
4.06
353
2738
(46235355) HIV 1 and 2 tests - Meaningful Use set
980
8536
1.18
5.10
1.6
1.9
—
—
—
0
0
(3021447) Carbon dioxide [Partial pressure] in Venous blood
276
3616
0.75
5.10
3.1
3.9
kpa
5.8
5.8
0.09
266
3506
(3039183) Clostridium tetani toxoid IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
8
6
13.35
5.07
1.1
1.0
—
—
—
0
0
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
194
1385
1.42
5.03
2.0
2.4
ug/l
253.8
550.9
2.41
173
1307
(3006442) Creatine [Moles/volume] in Serum or Plasma
58
308
1.89
5.00
1.6
1.5
umol/l
74.8
70.1
—
6
30
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
540
4451
1.24
5.00
3.9
4.4
u/l
224.6
241.9
2.34
507
4221
(3000991) Gas panel - Venous blood
252
3333
0.74
4.97
6.9
9.1
—
—
—
0
0
(4035726)
461
3738
1.26
4.95
1.5
1.4
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
521
4284
1.24
4.94
1.9
1.7
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
88
535
1.66
4.82
1.6
1.6
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
121
795
1.53
4.79
1.7
1.6
—
—
—
0
0
(3048402) Erythrocytes [#/area] in Urine sediment by Automated count
41
196
2.10
4.75
1.4
1.6
u/field
1.3
3.5
1.26
32
143
(3037121) Protein [Mass/volume] in Urine
193
1393
1.40
4.73
2.7
3.3
g/l
0.3
0.4
0.25
65
611
(3039000) Anion gap in Blood
136
920
1.49
4.70
4.3
8.1
mmol/l
11.1
11.4
0.36
118
823
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
1300
11643
1.15
4.70
1.7
1.6
mmol/l
1.4
1.4
0.36
1014
9879
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
33
145
2.28
4.69
1.1
1.3
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
136
921
1.49
4.68
4.3
8.1
mmol/l
105.1
105.2
0.07
118
824
(3035285) Chloride [Moles/volume] in Venous blood
14
427
0.33
4.68
4.8
2.2
mmol/l
106.1
105.6
0.22
14
419
(3041354) Potassium [Moles/volume] in Venous blood
14
427
0.33
4.68
4.8
2.2
mmol/l
4.0
4.0
0.04
14
419
(3025149) Bordetella pertussis IgA Ab [Units/volume] in Serum
52
274
1.91
4.62
1.1
1.1
iu/ml
6.7
9.7
0.57
12
75
(3008230) Borrelia burgdorferi IgM Ab [Units/volume] in Serum
395
3173
1.26
4.61
2.5
2.4
au/ml
27.5
23.7
0.22
21
197
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
34
153
2.23
4.58
2.0
2.1
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
106
685
1.56
4.54
1.1
1.1
u/ml
1.6
3.1
2.55
55
335
(40760888) Immunoglobulin light chains.free panel - Serum
127
854
1.50
4.54
2.9
3.7
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
14
415
0.34
4.44
4.8
2.3
—
—
—
0
0
(3012565) Volume of 24 hour Urine
45
229
1.97
4.43
1.8
2.3
ml
2053.8
1974.6
0.23
40
208
(3009015) Lactate [Moles/volume] in Synovial fluid
14
40
3.51
4.33
1.1
1.3
mmol/l
9.5
5.5
—
6
24
(4024509)
65
376
1.74
4.31
1.8
1.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
267
2061
1.31
4.27
2.4
2.3
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
66
385
1.72
4.25
2.9
2.7
—
—
—
0
0
(3014599) Egg white IgE Ab [Units/volume] in Serum
50
268
1.87
4.25
1.1
1.0
u/ml
0.7
0.7
0.02
16
57
(3041449) Collagen crosslinked C-telopeptide [Mass/volume] in Serum or Plasma
23
90
2.56
4.21
1.4
1.5
ug/l
0.5
0.4
0.68
16
61
(3037756) Immunofixation for Serum or Plasma
112
747
1.51
4.19
1.5
1.7
—
—
—
0
0
(3034860) Kappa light chains.free [Mass/volume] in Serum
159
1137
1.41
4.15
2.9
3.6
mg/l
55.1
56.8
0.03
100
918
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
159
1137
1.41
4.15
2.9
3.6
mg/l
26.2
59.3
1.89
102
918
(3045683) HLA typing for celiac disease panel - Blood or Tissue
52
286
1.83
4.09
1.0
1.0
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
36
175
2.06
4.04
1.9
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
36
175
2.06
4.04
1.9
1.4
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
285
3600
0.78
4.04
3.0
3.9
mmol/l
2.1
1.9
0.30
227
2924
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
147
1045
1.42
3.99
1.3
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
154
1105
1.41
3.96
2.8
3.5
ratio
0.9
2.2
—
10
86
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
46
246
1.88
3.96
2.0
1.7
—
—
—
0
0
(3015076) Soybean IgE Ab [Units/volume] in Serum
46
246
1.88
3.96
1.0
1.0
u/ml
0.8
2.5
—
5
35
(40761873) Peanut recombinant (rAra h) 1 IgE Ab [Units/volume] in Serum
13
38
3.43
3.90
1.0
1.0
u/ml
0.1
0.1
—
7
16
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
130
1833
0.70
3.89
2.2
3.0
%
1.2
1.3
0.31
130
1818
(3024889) Methemoglobin/Hemoglobin.total in Venous blood
126
1786
0.70
3.89
2.2
2.9
%
0.7
0.6
0.24
119
1707
(3020630) Protein [Mass/volume] in Serum or Plasma
391
3202
1.24
3.89
2.3
2.6
g/l
66.8
66.8
0.01
354
2953
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
565
4807
1.20
3.83
2.0
2.0
—
—
—
0
0
(3019060) Gas panel - Arterial blood
321
2576
1.26
3.82
3.9
5.4
—
—
—
0
0
(3046861) Legionella sp Ag [Presence] in Urine
9
15
6.01
3.81
1.0
1.0
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
193
1447
1.35
3.81
2.7
2.5
—
—
—
0
0
(3017704) Immunofixation for Urine
40
207
1.94
3.81
1.5
1.6
—
—
—
0
0
(40761847) Hazelnut recombinant (rCor a) 8 IgE Ab [Units/volume] in Serum
15
49
3.07
3.80
1.0
1.0
u/ml
0.0
0.2
—
8
30
(3034274) Bile acid [Moles/volume] in Serum --fasting
83
533
1.57
3.72
1.9
2.1
umol/l
8.8
6.8
0.40
55
382
(3012516) Albumin [Mass/volume] in Urine
1327
12067
1.13
3.72
3.4
3.3
mg/l
597.2
394.2
0.60
780
7692
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
116
800
1.46
3.72
2.6
3.1
—
—
—
0
0
(4034850)
99
1454
0.67
3.72
8.8
9.1
—
—
—
0
0
(40761872) Peanut recombinant (rAra h) 2 IgE Ab [Units/volume] in Serum
17
61
2.79
3.68
1.1
1.0
u/ml
0.2
1.9
—
10
38
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
511
4327
1.20
3.65
1.9
1.7
—
—
—
0
0
(3040151) Glucose [Moles/volume] in Capillary blood
70
434
1.62
3.64
4.7
20.5
mmol/l
7.0
7.2
0.15
62
366
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
25
110
2.28
3.61
1.0
1.1
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
1228
11138
1.13
3.57
4.4
3.9
%
20.6
21.6
1.41
569
4989
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
290
2320
1.26
3.56
1.0
1.0
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
2069
19356
1.11
3.53
11.2
9.2
e9/l
0.0
0.0
2.58
1779
15852
(3051593) INR in Capillary blood by Coagulation assay
31
151
2.06
3.50
1.7
11.4
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
598
5155
1.18
3.50
1.6
1.7
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
8
13
6.16
3.50
1.0
1.0
—
—
—
0
0
(40758558) Short blood count panel - Blood
996
11072
0.88
3.47
5.7
6.9
—
—
—
0
0
(3020874) Milk IgE Ab [Units/volume] in Serum
47
265
1.78
3.47
1.1
1.0
u/ml
1.2
1.8
0.16
15
69
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
157
2094
0.74
3.37
8.4
10.3
mmol/l
24.7
24.3
1.24
144
1973
(3021788) Differential panel - Synovial fluid
109
759
1.45
3.37
1.7
1.6
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
81
531
1.53
3.36
1.2
1.3
nmol/l
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
130
936
1.40
3.34
1.2
1.4
—
—
—
0
0
(3004119) Hemoglobin [Mass/volume] in Venous blood
184
2395
0.76
3.33
2.5
3.4
g/l
131.8
130.2
0.42
172
2333
(3026008) Bacteria identified in Urine by Culture
1243
11327
1.13
3.33
2.9
2.8
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
1431
13154
1.12
3.31
3.3
3.2
mmol/l
7.7
7.9
0.70
1155
11196
(3007919) Fasciola sp Ab [Titer] in Serum
6
7
8.58
3.26
1.2
1.0
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
9
19
4.74
3.23
1.1
1.6
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
231
1821
1.28
3.23
1.6
1.7
mg/l
4.0
3.7
0.13
177
1286
(3045414) Leukocytes [Presence] in Urine
243
1929
1.27
3.21
1.6
1.9
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
8
15
5.34
3.19
1.1
1.8
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
38
207
1.84
3.16
1.2
1.2
—
—
—
0
0
(3000012) Reticulocyte production index
36
193
1.87
3.14
1.4
1.6
—
—
—
0
0
(3041870) Hepatitis C virus IgG Ab [Presence] in Serum or Plasma by Immunoassay
16
61
2.63
3.13
1.1
1.0
—
—
—
0
0
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
119
855
1.40
3.12
1.7
1.5
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
26
125
2.09
3.07
1.2
1.2
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
615
5373
1.16
3.06
2.0
2.0
—
—
—
0
0
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
18
74
2.44
3.04
1.3
1.4
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
32
167
1.92
3.03
2.1
2.5
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
1373
12646
1.12
3.03
4.3
4.0
mg/mmol
10.3
9.3
0.13
802
8109
(40760007) HIV 1+2 Ab+HIV1 p24 Ag [Presence] in Serum or Plasma by Immunoassay
15
57
2.64
2.96
1.1
1.1
—
—
—
0
0
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
13
323
0.40
2.93
1.4
1.5
—
—
—
0
0
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
154
1168
1.33
2.90
3.0
3.3
mg/l
1.3
1.5
1.71
135
1091
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
23
458
0.50
2.89
1.1
1.2
—
—
—
0
0
(3004409) Coagulation factor X activity actual/normal in Platelet poor plasma by Coagulation assay
26
129
2.02
2.85
1.1
1.2
%
101.8
89.1
0.90
13
65
(4146454)
66
431
1.54
2.84
2.8
2.7
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
121
889
1.37
2.81
4.2
3.4
mg/l
22.8
24.5
0.18
59
537
(3011985) Renin [Units/volume] in Plasma
83
573
1.46
2.75
1.6
1.5
mu/l
84.0
51.4
0.63
70
511
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
12
42
2.86
2.74
1.2
1.1
—
—
—
0
0
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
26
131
1.99
2.74
1.0
1.0
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
37
210
1.77
2.74
1.2
1.1
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
128
954
1.35
2.73
1.4
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
22
105
2.10
2.68
1.1
1.1
—
—
—
0
0
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
147
1908
0.76
2.67
2.9
4.3
mmol/l
24.3
24.2
0.09
129
1719
(40767663) Brazil Nut recombinant (rBer e) 1 IgE Ab [Units/volume] in Serum
9
24
3.75
2.67
1.0
1.0
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
51
319
1.60
2.65
1.2
1.1
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
29
154
1.89
2.65
2.6
2.8
—
—
—
0
0
(3005353) Prothrombin activity actual/normal in Platelet poor plasma by Coagulation assay
26
133
1.96
2.64
1.1
1.1
%
91.7
88.9
0.24
12
68
(3020393) Adenovirus Ag [Presence] in Stool
10
32
3.13
2.64
1.4
1.0
—
—
—
0
0
(3042299) inFLIXimab [Mass/volume] in Serum or Plasma
32
176
1.82
2.63
2.8
3.1
mg/l
8.9
7.8
0.40
27
140
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
896
8116
1.13
2.63
3.2
2.8
ug/l
0.7
0.7
0.84
544
5068
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
49
305
1.61
2.61
1.2
1.2
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
63
417
1.52
2.58
1.3
1.5
—
—
—
0
0
(40771527) Human papilloma virus E6+E7 mRNA [Presence] in Cervix by NAA with probe detection
31
170
1.83
2.58
1.6
1.9
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
62
2.42
2.53
1.1
1.5
—
—
—
0
0
(3034426) Prothrombin time (PT)
6
178
0.34
2.53
2.0
1.2
—
—
—
0
0
(3000034) Microalbumin [Mass/volume] in Urine
21
409
0.51
2.51
3.7
3.1
mg/l
11.0
56.5
2.27
16
300
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
61
404
1.52
2.50
1.2
1.4
—
—
—
0
0
(3018301) Testosterone Free [Moles/volume] in Serum or Plasma
61
405
1.51
2.48
1.4
1.4
pmol/l
57.0
142.3
0.62
25
129
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
267
2213
1.22
2.47
1.7
1.6
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
43
265
1.63
2.40
2.9
2.7
%
43.2
40.3
0.40
26
88
(3009542) Hematocrit [Volume Fraction] of Blood
4222
41326
1.11
2.38
13.3
13.8
%
40.9
40.3
6.01
2896
31448
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
8
22
3.64
2.36
1.0
1.0
—
—
—
0
0
(3033086) Enterovirus NOS Ab [Titer] in Serum
7
17
4.12
2.36
1.0
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
60
879
0.68
2.35
1.9
3.4
—
—
—
0
0
(4094501)
161
1269
1.28
2.35
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
70
995
0.70
2.33
1.2
1.2
—
—
—
0
0
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
262
2182
1.21
2.33
2.5
3.3
u/ml
34.1
50.1
0.89
254
2101
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
86
1180
0.72
2.33
1.4
1.5
—
—
—
0
0
(3011841) English Walnut IgE Ab [Units/volume] in Serum
10
35
2.86
2.30
1.0
1.0
u/ml
0.0
0.2
—
5
23
(3045788) Cell count panel - Pleural fluid
17
339
0.50
2.22
1.4
1.5
—
—
—
0
0
(3032743) Legionella sp IgG Ab [Presence] in Serum
9
29
3.11
2.22
1.0
1.0
—
—
—
0
0
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
338
2895
1.18
2.22
2.8
4.0
ng/l
68.3
89.7
8.32
289
2545
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
16
73
2.20
2.20
3.3
2.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
53
352
1.51
2.19
1.1
1.1
—
—
—
0
0
(3035457) Cefaclor IgE Ab [Units/volume] in Serum
11
42
2.62
2.18
1.1
1.1
—
—
—
0
0
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
17
80
2.13
2.18
1.1
1.5
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
36
218
1.66
2.18
1.3
1.6
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
9
30
3.00
2.14
1.0
1.0
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
75
536
1.41
2.14
1.3
1.4
pmol/l
290.1
288.7
0.01
56
398
(3018851) Theophylline [Moles/volume] in Serum or Plasma
10
37
2.71
2.10
1.9
1.7
umol/l
44.2
45.7
—
10
37
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
119
917
1.30
2.10
5.6
5.8
iu/ml
336.8
520.9
0.45
15
140
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
8
193
0.41
2.03
3.8
2.8
—
—
—
0
0
(3000285) Sodium [Moles/volume] in Blood
0
58
0.00
2.03
0.0
1.1
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
56
383
1.47
2.03
1.5
1.4
e6/l
14253.0
48792.7
1.06
27
266
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
112
861
1.31
2.02
3.2
3.7
u/ml
144.6
638.1
0.94
99
794
(42529188) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma by Immunoassay
11
44
2.50
2.01
3.2
1.1
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
24
133
1.81
1.99
1.1
1.2
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
41
623
0.66
1.98
1.6
1.6
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
55
377
1.46
1.98
1.2
1.1
—
—
—
0
0
(3023939) Sjogrens syndrome-A extractable nuclear Ab [Units/volume] in Serum
124
970
1.29
1.97
1.2
1.3
u/ml
49.1
46.5
0.05
14
101
(3006462) Nitrate [Presence] in Urine
31
186
1.67
1.97
2.8
3.0
—
—
—
0
0
(3022621) pH of Urine by Test strip
313
2695
1.17
1.96
2.5
2.7
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
40
609
0.65
1.96
1.4
1.7
—
—
—
0
0
(3048879) Bone marrow aspiration report
21
112
1.88
1.95
1.2
1.9
—
—
—
0
0
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
139
1105
1.26
1.95
2.0
1.9
iu/l
4.6
4.7
0.03
62
422
(3027953) Aldolase [Enzymatic activity/volume] in Serum or Plasma
42
273
1.54
1.94
2.0
1.5
u/l
4.8
7.1
2.13
37
237
(3034770) Mitochondria Ab [Titer] in Serum
159
1287
1.24
1.91
1.2
1.3
titre
624.0
1062.4
—
5
38
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
61
853
0.71
1.91
1.6
1.7
—
—
—
0
0
(3036185) Alkaline phosphatase.liver 2 [Enzymatic activity/volume] in Serum or Plasma
34
211
1.62
1.91
1.1
1.1
u/l
25.9
22.9
0.12
29
164
(3023410) Appearance of Cerebral spinal fluid
29
471
0.61
1.90
1.3
1.6
—
—
—
0
0
(3014111) Lactate [Moles/volume] in Serum or Plasma
304
3511
0.86
1.86
5.5
7.6
mmol/l
1.3
1.3
1.12
292
3386
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
372
3260
1.15
1.86
2.1
2.3
ug/l
7.3
8.0
0.16
325
2938
(3001019) Free T4 and TSH panel - Serum or Plasma
317
2747
1.16
1.85
1.7
1.7
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
39
253
1.55
1.83
1.5
1.5
u/l
12.7
12.4
0.05
39
243
(3024474) Albumin [Mass/volume] in Cerebral spinal fluid
53
367
1.45
1.83
1.1
1.1
mg/l
254.6
275.0
0.35
44
317
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
17
314
0.54
1.80
1.0
1.2
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
22
123
1.79
1.79
1.2
1.5
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
583
5273
1.12
1.79
1.3
1.4
—
—
—
0
0
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
143
1154
1.25
1.79
1.3
1.3
mg/l
575.5
522.5
0.39
135
1095
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
28
169
1.66
1.76
1.3
1.2
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
54
379
1.43
1.75
1.1
1.1
mg/l
46.5
41.2
0.25
42
318
(3000475) Leukocytes [#/volume] in Synovial fluid
126
1005
1.26
1.75
1.7
1.7
e6/l
9497.8
12240.1
0.46
87
721
(3003458) Phosphate [Moles/volume] in Serum or Plasma
587
5320
1.12
1.74
4.5
6.3
mmol/l
1.0
1.0
0.39
551
4990
(3030313) Adrenal Ab [Titer] in Serum
9
36
2.50
1.73
1.2
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
20
348
0.57
1.73
1.8
2.2
%
11.5
11.3
0.06
20
348
(40768795) Lymph node Pathology biopsy report
57
405
1.41
1.73
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
173
1431
1.22
1.73
1.2
1.2
—
—
—
0
0
(3014891) Appearance of Pleural fluid
0
46
0.00
1.70
0.0
1.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
22
126
1.75
1.67
1.3
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
16
293
0.54
1.67
1.3
1.6
—
—
—
0
0
(3018418) pH of Serum or Plasma
1272
11982
1.08
1.66
3.7
4.2
ph
7.4
7.4
0.60
396
2298
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
13
62
2.10
1.65
1.2
1.1
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
5
14
3.57
1.61
1.0
1.0
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
43
295
1.46
1.59
1.5
1.9
u/field
1.9
1.8
0.03
27
122
(3023199) Leukocytes [#/volume] in Pleural fluid
27
425
0.63
1.59
1.3
1.5
e6/l
2464.6
2342.0
0.04
22
311
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
8
172
0.46
1.57
1.1
1.1
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
1188
12601
0.93
1.57
1.5
1.4
—
—
—
0
0
(3008152) Bicarbonate [Moles/volume] in Arterial blood
284
2478
1.15
1.55
5.5
7.7
mmol/l
24.6
24.4
0.33
262
2310
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
26
160
1.63
1.55
1.1
1.1
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
260
2256
1.16
1.54
1.4
1.5
—
—
—
0
0
(4281824)
29
445
0.65
1.53
1.0
1.1
—
—
—
0
0
(3041365) Herpes simplex virus IgG Ab [Units/volume] in Serum by Immunoassay
14
71
1.97
1.53
1.1
1.1
—
—
—
0
0
(3004451) EKG impression Narrative
31
200
1.55
1.53
1.4
1.3
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
135
1105
1.23
1.53
1.4
1.3
—
—
—
0
0
(3014591) Smooth Alder IgE Ab [Units/volume] in Serum
5
15
3.34
1.52
1.0
1.0
—
—
—
0
0
(3012984) Norclozapine [Mass/volume] in Serum or Plasma
0
43
0.00
1.52
0.0
9.0
—
—
—
0
0
(3016273) Islet cell 512 Ab [Units/volume] in Serum
7
27
2.59
1.51
1.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
23
138
1.67
1.51
1.3
1.2
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
156
1300
1.21
1.49
1.2
1.3
titre
101.8
157.9
0.45
11
112
(3048518) aPTT.lupus sensitive actual/normal (normalized LA screen)
43
300
1.44
1.48
1.2
1.1
ratio
1.0
1.0
—
9
112
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
23
139
1.66
1.48
1.1
1.2
—
—
—
0
0
(3036669) Protein S actual/normal in Platelet poor plasma by Coagulation assay
34
227
1.50
1.46
1.0
1.1
%
93.3
95.0
0.15
26
182
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
86
1092
0.78
1.46
1.3
1.4
—
—
—
0
0
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
116
1423
0.81
1.45
2.9
3.7
u/ml
2981.5
3689.7
0.08
102
1220
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
18
304
0.59
1.44
1.7
1.6
—
—
—
0
0
(3001556) Androgen free Index in Serum or Plasma
11
52
2.12
1.44
1.1
1.1
—
—
—
0
0
(42870308) Desmosome IgG Ab [Titer] in Serum by Immunofluorescence
32
212
1.51
1.43
1.4
1.3
titre
20.0
66.3
—
6
19
(3036048) Francisella tularensis Ab [Titer] in Serum
19
110
1.73
1.42
1.1
1.2
—
296.0
—
0
5
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
87
1097
0.79
1.40
1.3
1.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
37
254
1.46
1.40
1.5
1.4
u/ml
22.5
21.0
—
8
48
(3027273) Bicarbonate [Moles/volume] in Venous blood
154
1829
0.84
1.39
3.0
3.4
mmol/l
25.5
25.3
0.51
149
1767
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
87
1096
0.79
1.39
1.3
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
87
1096
0.79
1.39
1.3
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
9
178
0.50
1.39
1.1
1.1
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
71
545
1.31
1.39
1.2
1.3
—
—
—
0
0
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
72
554
1.30
1.38
5.4
6.8
mg/l
11.0
11.4
0.41
66
514
(4211845)
31
206
1.51
1.37
2.7
2.9
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
9
41
2.20
1.37
1.2
1.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
161
0.50
1.35
1.0
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
164
0.49
1.35
1.0
1.0
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
36
248
1.45
1.35
1.1
1.2
—
—
—
0
0
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
50
366
1.37
1.34
1.3
1.2
titre
226.7
208.7
—
9
72
(3027923) C peptide [Moles/volume] in Serum or Plasma
35
240
1.46
1.34
1.9
1.3
nmol/l
1.5
1.2
0.79
24
184
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
26
167
1.56
1.34
1.5
1.5
pmol/l
14.4
15.0
0.22
21
143
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
98
789
1.25
1.33
1.3
1.3
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
98
789
1.25
1.33
1.3
1.3
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
76
966
0.78
1.32
2.2
2.1
—
—
—
0
0
(4198724)
12
220
0.54
1.31
1.0
2.9
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
25
380
0.66
1.30
1.3
1.5
e6/l
8775.4
89160.2
3.00
15
229
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
51
378
1.35
1.28
1.2
1.1
mg/l
268.0
288.7
1.54
43
343
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
57
430
1.33
1.28
3.6
5.1
u/ml
175.0
67.0
0.32
18
125
(1001926) Buprenorphine [Presence] in Urine by Screen method
172
1471
1.18
1.27
1.9
2.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
52
388
1.34
1.26
1.5
1.5
g/l
0.9
1.0
0.23
52
388
(3052851) Hemolysis interference index of Serum or Plasma
101
1234
0.81
1.25
2.8
3.1
—
—
—
0
0
(1175556) inFLIXimab Ab [Units/volume] in Serum by Immunoassay
25
162
1.55
1.25
2.6
2.6
au/ml
43.3
148.5
—
5
25
(4038314)
6
25
2.40
1.24
1.2
1.2
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
27
399
0.68
1.24
3.3
3.3
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
159
0.50
1.24
3.0
2.2
—
—
—
0
0
(3050794) Legionella sp Ab [Presence] in Serum
9
45
2.00
1.23
1.0
1.1
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
323
3596
0.89
1.23
1.4
1.5
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
25
374
0.67
1.22
1.4
1.6
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
36
255
1.41
1.19
1.3
1.3
—
—
—
0
0
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
10
50
2.00
1.16
1.4
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
24
357
0.67
1.16
1.5
1.5
—
—
—
0
0
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1557
14944
1.06
1.15
3.2
3.3
u/l
30.4
35.3
2.36
1456
14253
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
93
1133
0.82
1.15
2.0
2.2
g/l
0.0
0.0
0.08
87
1055
(44790047)
63
491
1.29
1.15
1.8
1.4
—
—
—
0
0
(44790049)
63
491
1.29
1.15
1.8
1.4
—
—
—
0
0
(44790048)
63
491
1.29
1.15
1.8
1.4
—
—
—
0
0
(44806118)
63
491
1.29
1.15
1.8
1.4
—
—
—
0
0
(3044889) 12 lead EKG panel
3116
30480
1.05
1.14
3.9
3.5
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
35
249
1.41
1.14
1.3
1.1
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
39
283
1.38
1.14
1.1
1.1
nmol/l
2.6
5.6
0.62
11
58
(3023323) Follitropin [Units/volume] in Serum or Plasma
257
2285
1.13
1.14
1.3
1.3
iu/l
25.7
28.7
0.85
226
1972
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
88
715
1.23
1.14
1.4
1.5
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
27
183
1.48
1.13
1.3
1.1
ng/l
552.4
389.0
—
7
42
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
96
1159
0.83
1.09
1.8
2.2
g/l
38.6
37.9
0.44
83
1023
(3022689) Creatine [Moles/volume] in Urine
7
138
0.51
1.09
1.7
1.5
—
—
—
0
0
(3027401) Testosterone Free/Testosterone.total in Serum or Plasma
5
21
2.38
1.09
1.0
1.4
%
1.3
1.3
—
5
21
(3011325) HIV 1+2 Ab [Presence] in Serum
5
21
2.38
1.09
1.0
1.0
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
11
59
1.87
1.07
3.2
1.6
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
80
649
1.24
1.06
1.3
1.4
mmol/l
68.9
64.3
0.45
64
522
(3009876) Amylase isoenzyme 3 panel - Serum or Plasma
7
33
2.12
1.05
1.3
1.2
—
—
—
0
0
(4268621)
37
499
0.74
1.05
2.6
2.2
—
—
—
0
0
(3021387) Prolactin [Units/volume] in Serum or Plasma
192
1688
1.14
1.03
1.7
1.6
mu/l
295.4
292.6
0.03
171
1530
(3044242) Glucose [Moles/volume] in Arterial blood
12
203
0.59
1.03
1.5
2.2
—
—
—
0
0
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
7
34
2.06
1.02
1.0
1.3
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
11
60
1.84
1.02
1.4
1.1
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
17
106
1.61
1.02
1.0
1.1
—
—
—
0
0
(42529598) SUMO-activating enzyme subunit 1 Ab [Presence] in Serum by Line blot
17
106
1.61
1.02
1.1
1.1
—
—
—
0
0
(42529582) MDA5 Ab [Presence] in Serum by Line blot
17
106
1.61
1.02
1.1
1.1
—
—
—
0
0
(42528593) TIF1-gamma Ab [Presence] in Serum by Line blot
17
106
1.61
1.02
1.1
1.1
—
—
—
0
0
(3013637) Mi-2 Ab [Presence] in Serum
17
106
1.61
1.02
1.1
1.1
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
19
122
1.56
1.02
1.2
1.1
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
19
122
1.56
1.02
1.2
1.1
—
—
—
0
0
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
130
1111
1.17
1.02
1.5
1.4
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
10
53
1.89
1.01
1.0
1.1
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
12
68
1.77
1.00
3.7
3.2
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
13
76
1.71
0.98
3.2
2.7
ml/dl
15.7
15.0
0.46
13
71
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
40
300
1.34
0.98
1.6
1.5
mmol/l
8.1
7.9
0.24
33
190
(3026782) Osmolality of Urine
842
7975
1.07
0.97
2.8
2.7
mosm/kgh2o
534.9
549.2
1.08
742
6807
(3002621) Streptococcal DNAse B [Units/volume] in Serum
7
36
1.95
0.97
1.0
1.1
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
752
7097
1.07
0.96
1.5
1.6
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
18
116
1.55
0.96
1.2
1.1
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
58
460
1.26
0.96
1.1
1.1
—
—
—
0
0
(3024263) Appearance of Synovial fluid
15
235
0.64
0.95
1.5
1.8
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
267
2953
0.90
0.95
1.9
2.0
—
—
—
0
0
(3016750) Collection duration of Urine
34
250
1.36
0.95
2.3
2.2
min
486.6
493.0
0.20
23
185
(3039443) Prostate specific Ag panel - Serum or Plasma
118
1008
1.17
0.95
1.6
1.6
—
—
—
0
0
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
119
1018
1.17
0.94
1.2
1.3
mmol/l
3.7
3.8
0.50
112
952
(3001501) Glucose [Moles/volume] in Capillary blood by Glucometer
14
85
1.65
0.94
2.1
2.2
mmol/l
6.5
7.9
—
8
47
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
179
1579
1.14
0.94
1.5
1.4
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
11
62
1.78
0.94
1.4
1.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
129
1489
0.86
0.91
2.4
2.3
g/l
3.7
3.8
0.34
91
1089
(3047189) Immunofixation for 24 hour Urine
26
184
1.42
0.91
1.6
1.7
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
30
218
1.38
0.91
1.1
1.1
miu/ml
1286.9
1502.3
0.55
30
218
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
129
1488
0.86
0.90
2.4
2.3
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
15
94
1.60
0.90
1.2
1.1
—
—
—
0
0
(3000515) Antithrombin actual/normal in Platelet poor plasma by Chromogenic method
124
1433
0.86
0.89
2.1
2.1
%
91.6
91.8
0.04
111
1338
(3020191) Ethanol [Moles/volume] in Serum or Plasma
49
385
1.28
0.89
1.3
1.6
promille
1.1
1.3
0.67
38
290
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
12
71
1.69
0.88
1.2
1.7
—
—
—
0
0
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
19
127
1.50
0.88
1.2
1.1
—
—
—
0
0
(3030981) Hyaline casts [#/volume] in Urine by Automated count
234
2109
1.11
0.88
2.7
2.7
e6/l
0.1
0.3
2.32
226
2050
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
13
79
1.65
0.88
1.0
1.1
—
—
—
0
0
(3022058) Hepatitis B virus DNA [Presence] in Serum or Plasma by NAA with probe detection
15
95
1.58
0.87
1.5
1.3
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
23
322
0.71
0.85
1.0
1.0
—
—
—
0
0
(3017569) Oxygen content in Arterial blood
12
192
0.62
0.85
1.9
2.3
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
69
834
0.83
0.85
2.4
3.0
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
78
650
1.20
0.85
1.3
1.2
—
—
—
0
0
(1002224) Polysomnography panel
238
2153
1.11
0.84
1.1
1.1
—
—
—
0
0
(3019174) dRVVT (LA screen)
8
45
1.78
0.84
1.1
1.2
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
12
191
0.63
0.84
1.1
1.6
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
40
309
1.30
0.83
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
112
0.54
0.83
6.7
7.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
344
3174
1.09
0.82
1.5
1.4
—
—
—
0
0
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
581
6165
0.94
0.82
1.6
1.8
%
1.4
1.4
0.06
495
5489
(3009466) Valproate [Moles/volume] in Serum or Plasma
54
665
0.81
0.81
5.0
5.5
umol/l
343.0
370.0
0.73
43
578
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
19
130
1.46
0.80
1.2
1.1
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
8
47
1.70
0.80
1.1
2.6
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
10
58
1.73
0.79
1.0
1.0
—
—
—
0
0
(3024316) Viscosity of Plasma
0
24
0.00
0.79
0.0
1.5
—
1.9
—
0
13
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
25
0.00
0.79
0.0
3.6
—
—
—
0
0
(3018095) Leukocytes [#/volume] in Urine
1424
14717
0.96
0.78
3.4
3.5
e6/l
56.8
87.6
1.29
1099
10352
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
131
1489
0.88
0.78
2.4
2.3
g/l
7.2
7.4
0.29
99
1137
(4027681)
37
287
1.29
0.76
1.3
1.2
—
—
—
0
0
(44786774) Adalimumab [Mass/volume] in Serum or Plasma
22
157
1.40
0.76
1.5
2.0
mg/l
8.5
9.4
0.30
15
132
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
58
476
1.22
0.76
1.2
1.1
—
—
—
0
0
(3020123) Porphyrins [Interpretation] in Serum or Plasma
5
24
2.08
0.74
1.4
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
5
24
2.08
0.74
2.2
4.6
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
85
725
1.18
0.74
1.2
1.2
—
—
—
0
0
(3005812) Immunoglobulin light chains [Presence] in 24 hour Urine
7
38
1.84
0.73
3.4
2.3
—
—
—
0
0
(3029790) Creatine kinase.MB [Enzymatic activity/volume] in Serum or Plasma
7
38
1.84
0.73
1.0
1.2
u/l
9.1
18.3
—
7
38
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
46
370
1.25
0.72
1.3
1.3
mmol/l
12.2
12.5
—
6
102
(3037556) Urate [Mass/volume] in Serum or Plasma
18
125
1.44
0.72
1.2
1.3
—
—
—
0
0
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
106
0.57
0.72
1.3
1.3
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
72
608
1.19
0.71
1.2
1.2
—
—
—
0
0
(40763634) TCRG gene rearrangements [Presence] in Bone marrow by Molecular genetics method
7
40
1.75
0.71
1.0
1.1
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
122
1380
0.88
0.70
2.3
2.3
g/l
10.1
10.3
0.24
98
1193
(3020491) Glucose [Moles/volume] in Blood
40
319
1.26
0.69
1.9
1.8
mmol/l
6.3
6.6
0.53
31
215
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
13
85
1.53
0.68
1.0
1.2
—
—
—
0
0
(42868499) Enterovirus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
59
1.53
0.68
1.1
1.0
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
59
492
1.20
0.68
1.3
1.4
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
7
120
0.58
0.67
3.9
1.3
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
751
7180
1.05
0.67
1.5
1.5
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
58
484
1.20
0.66
1.1
1.2
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
1104
11431
0.96
0.66
3.0
3.0
e6/l
0.3
0.4
0.31
873
8544
(3004716) Salmonella sp identified in Stool by Organism specific culture
210
2296
0.91
0.66
1.5
1.4
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
330
3537
0.93
0.65
2.1
2.5
ml/min/173m2
73.3
69.4
1.14
155
1334
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
7
44
1.59
0.65
2.0
2.0
—
—
—
0
0
(3017962) TCRG gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
7
44
1.59
0.65
1.3
1.4
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
193
1759
1.10
0.64
1.8
2.3
—
—
—
0
0
(3020356) Listeria sp identified in Specimen by Organism specific culture
5
29
1.72
0.64
1.2
1.1
—
—
—
0
0
(3020148) Glutamate decarboxylase 65 Ab [Units/volume] in Serum
85
737
1.16
0.63
1.2
1.1
iu/ml
17.9
13258.4
0.54
29
177
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
114
1285
0.88
0.63
3.1
3.2
u/ml
0.4
0.3
1.53
76
725
(3042733) HLA Ab [Presence] in Serum
11
165
0.67
0.62
2.2
4.9
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
30
234
1.28
0.62
1.7
1.4
nmol/l
138.1
136.5
0.09
30
234
(3028717) Thiamine [Mass/volume] in Blood
8
49
1.63
0.62
1.0
1.3
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
8
51
1.57
0.60
1.9
1.4
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
24
183
1.31
0.59
1.2
1.1
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
47
390
1.21
0.59
1.9
2.1
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
16
114
1.40
0.58
2.1
2.0
u/l
16.3
59.4
1.24
16
106
(3016650) Hepatitis A virus Ab [Presence] in Serum
70
809
0.86
0.58
1.1
1.1
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
6
36
1.67
0.56
1.0
1.1
—
—
—
0
0
(3043849) Epstein Barr virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
80
699
1.15
0.56
3.2
2.7
u/ml
379.4
1425.1
0.93
11
39
(3035933) Granulocytes/100 leukocytes in Blood
19
141
1.35
0.56
1.3
1.5
—
—
—
0
0
(3005411) Squamous cell carcinoma Ag [Mass/volume] in Serum or Plasma
5
89
0.56
0.56
1.2
2.0
ug/l
1.9
1.9
—
5
43
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
114
1271
0.89
0.55
2.3
2.4
g/l
1.4
0.9
0.25
94
1122
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
13
90
1.45
0.55
2.2
3.3
u/l
81.9
118.3
—
8
29
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
812
7824
1.04
0.55
3.5
3.5
ng/l
396.1
609.2
0.59
542
5724
(4133840)
18
133
1.35
0.55
1.2
1.2
—
—
—
0
0
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
55
644
0.85
0.54
1.3
1.3
mmol/l
7.8
7.3
0.29
41
485
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
430
4532
0.94
0.54
6.1
8.0
kpa
5.1
5.1
0.05
397
4336
(42868497) Enterovirus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
38
1.58
0.54
1.2
1.1
—
—
—
0
0
(3027801) Oxygen [Partial pressure] in Arterial blood
430
4531
0.94
0.54
6.1
8.0
kpa
12.2
12.6
0.77
401
4332
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
6
39
1.54
0.53
2.2
2.2
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
203
1877
1.08
0.53
1.8
2.1
—
—
—
0
0
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
9
63
1.43
0.52
1.0
1.0
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
54
463
1.17
0.50
1.4
1.4
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
23
180
1.28
0.49
1.2
1.0
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
358
3776
0.94
0.48
6.7
9.0
g/l
126.9
122.7
3.16
336
3643
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
7
110
0.64
0.48
1.0
1.1
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
21
163
1.29
0.48
1.1
1.1
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
72
816
0.88
0.48
1.0
1.1
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
83
932
0.89
0.48
2.4
2.0
nmol/l
0.9
0.8
0.53
70
787
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
74
653
1.14
0.47
1.1
1.1
—
—
—
0
0
(3036071) Salmonella sp Ab [Titer] in Serum
12
166
0.72
0.47
1.2
1.1
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
85
952
0.89
0.47
4.2
3.0
umol/l
30.2
36.0
1.76
70
827
(3027008) Opiates [Presence] in Urine
205
1911
1.08
0.46
1.8
2.1
—
—
—
0
0
(3002148) Methylenedioxymethamphetamine [Presence] in Urine by Screen method
17
221
0.77
0.46
1.1
3.0
—
—
—
0
0
(3009991) Angiotensin converting enzyme [Enzymatic activity/volume] in Cerebral spinal fluid
33
273
1.21
0.46
1.2
1.1
u/l
1.0
1.1
0.47
20
131
(3043410) Blood group antigens tested for on Red Blood Cells
8
119
0.67
0.45
1.3
1.7
—
—
—
0
0
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
45
525
0.86
0.45
1.2
1.1
%
92.5
96.9
0.67
40
498
(3026051) Polymorphonuclear cells/100 leukocytes in Pleural fluid
5
85
0.59
0.45
1.2
1.4
%
14.0
25.3
—
5
68
(3021162) Amylase [Enzymatic activity/volume] in Specimen
5
85
0.59
0.45
4.0
3.0
u/l
65.0
2288.9
—
5
76
(3045716) Anion gap in Serum or Plasma
14
186
0.75
0.44
2.9
2.7
mmol/l
7.4
9.6
—
5
143
(3028300) Cannabinoids [Presence] in Urine
205
1915
1.07
0.44
1.9
2.2
—
—
—
0
0
(43055222) Platelet function.collagen + Adenosine diphosphate induced and EPINEPHrine induced panel - Blood
7
51
1.37
0.44
1.1
1.3
—
—
—
0
0
(40758292) HTLV I+II Ab panel - Serum
11
78
1.41
0.43
1.7
1.4
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
140
1518
0.92
0.43
1.3
1.3
miu/ml
164.2
219.7
1.58
75
717
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
218
2323
0.94
0.42
1.9
1.9
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
203
1899
1.07
0.42
1.9
2.2
—
—
—
0
0
(3006109) Coagulation factor IX activity actual/normal in Platelet poor plasma by Coagulation assay
12
87
1.38
0.42
1.2
1.3
%
121.1
107.5
0.69
12
81
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
129
1401
0.92
0.41
2.4
2.3
g/l
2.9
3.1
2.10
95
1115
(3018677) aPTT in Platelet poor plasma by Coagulation assay
655
6331
1.04
0.41
2.0
2.1
s
28.8
29.7
5.31
622
6148
(3034614) HLA Ag [Interpretation]
0
15
0.00
0.41
0.0
1.1
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
29
240
1.21
0.41
1.3
1.1
—
—
—
0
0
(3007302) Hemoglobin [Mass/volume] in Mixed venous blood
0
16
0.00
0.41
0.0
9.3
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
689
7117
0.96
0.40
2.3
3.0
mmol/l
2.4
2.4
0.50
601
6245
(3022217) INR in Platelet poor plasma by Coagulation assay
508
4886
1.04
0.40
19.0
21.4
inr
1.3
1.3
0.11
136
744
(3023530) 17-Hydroxyprogesterone [Moles/volume] in Serum or Plasma
0
17
0.00
0.40
0.0
1.4
—
2.0
—
0
17
(40757578) FLT3 gene targeted mutation analysis in Bone marrow by Molecular genetics method
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3012215) Mononuclear cells/100 leukocytes in Synovial fluid
15
114
1.32
0.40
1.3
1.4
%
43.9
31.8
—
7
74
(3027456) Digoxin [Moles/volume] in Serum or Plasma
50
572
0.87
0.40
2.9
3.1
nmol/l
0.8
0.8
0.02
37
440
(40760410) HLA-B [Type] by High resolution
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(46236302) HLA-C [Type] by High resolution typing
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(40760409) HLA-A [Type] by High resolution
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(40763590) HLA-DQ beta [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(3013862) HLA-DP [Type]
0
18
0.00
0.40
0.0
1.0
—
—
—
0
0
(44806071)
8
61
1.31
0.39
1.0
1.0
—
—
—
0
0
(3039744) RNA polymerase III Ab [Units/volume] in Serum
5
36
1.39
0.38
1.0
1.1
—
3.4
—
0
5
(3036489) Thrombin time
156
1671
0.93
0.37
1.9
2.0
s
21.6
21.5
0.09
125
1446
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
9
70
1.29
0.36
1.2
1.8
ng/l
80.3
142.6
—
9
70
(3003396) Base excess in Arterial blood by calculation
435
4522
0.96
0.36
6.0
8.1
mmol/l
1.3
1.0
1.03
322
3530
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
25
207
1.21
0.36
1.1
1.1
iu/ml
123.9
171.7
0.97
25
207
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
25
207
1.21
0.36
1.6
1.6
nmol/l
3.7
6.5
0.43
18
165
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
34
291
1.17
0.35
5.5
6.8
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
20
162
1.24
0.35
1.7
1.7
—
—
—
0
0
(43055442) Apixaban [Mass/volume] in Serum or Plasma
6
43
1.40
0.35
1.3
1.3
ug/l
120.7
118.6
—
6
37
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
125
0.72
0.35
1.1
3.6
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
125
0.72
0.35
1.1
3.6
—
—
—
0
0
(3020779) Urea [Moles/volume] in Serum or Plasma
378
3629
1.04
0.35
6.3
8.2
mmol/l
8.1
9.3
2.23
355
3478
(3046426) Aquaporin 4 water channel IgG Ab [Presence] in Serum or Plasma
10
73
1.37
0.34
1.0
1.0
—
—
—
0
0
(3016502) Oxygen saturation in Arterial blood
389
4046
0.96
0.34
6.2
8.5
%
96.0
95.9
0.18
368
3903
(3048522) Glucose [Moles/volume] in Serum or Plasma --pre dose glucose
6
45
1.33
0.33
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
490
4735
1.04
0.33
1.8
1.7
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
123
1322
0.93
0.33
1.6
1.4
—
—
—
0
0
(3012741) Chlamydophila pneumoniae IgA Ab [Titer] in Serum
6
47
1.28
0.32
1.0
1.1
—
—
—
0
0
(42868418) European tick borne encephalitis virus IgG Ab [Presence] in Cerebral spinal fluid by Immunoassay
7
52
1.35
0.31
1.3
1.1
—
—
—
0
0
(3031072) Herpes simplex virus 1 IgG Ab [Presence] in Cerebral spinal fluid
7
55
1.27
0.30
1.0
1.1
—
—
—
0
0
(3018133) Calcium [Moles/volume] in Urine
7
55
1.27
0.30
1.9
1.9
mmol/l
1.8
3.1
—
7
50
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
12
93
1.29
0.30
2.1
2.2
umol/l
14.0
17.2
0.53
12
93
(3042111) Morphology [Interpretation] in Bone marrow Narrative
60
661
0.91
0.29
1.3
1.7
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
31
269
1.15
0.29
1.3
1.5
u/l
14.0
5.6
0.93
12
137
(3007695) Herpes simplex virus 2 IgG Ab [Presence] in Cerebral spinal fluid
7
57
1.23
0.29
1.0
1.1
—
—
—
0
0
(3022493) Free Hemoglobin [Mass/volume] in Plasma
21
176
1.19
0.28
3.2
5.1
mg/l
83.8
59.7
0.97
12
125
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
92
853
1.08
0.28
1.9
1.7
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
180
1710
1.05
0.27
1.6
1.9
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
60
547
1.10
0.27
2.7
2.4
—
—
—
0
0
(21494434) Karyotype in Bone marrow
39
347
1.12
0.26
1.2
1.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
137
1293
1.06
0.26
2.2
2.6
g/l
3.7
3.6
0.47
128
1226
(3029396) Erythrocyte agglutination [Presence] in Blood
13
104
1.25
0.26
3.2
2.9
—
—
—
0
0
(3013293) Extractable nuclear Ab [Presence] in Serum
5
72
0.69
0.26
1.4
1.7
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
111
1182
0.94
0.26
4.7
4.5
mmol/l
3.8
3.9
1.51
103
1109
(3041806) Other cells [#/volume] in Blood by Manual count
16
132
1.21
0.25
1.7
1.6
—
—
—
0
0
(3024869) Neuronal Ab [Presence] in Serum
9
76
1.18
0.24
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
45
407
1.11
0.24
1.3
1.3
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
9
77
1.17
0.24
2.7
1.5
—
—
—
0
0
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
69
743
0.93
0.23
1.4
1.2
u/ml
6.1
3.6
0.34
22
244
(40768800) Prostate Pathology biopsy report
86
805
1.07
0.22
1.2
1.2
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
56
516
1.09
0.22
1.1
1.1
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
49
449
1.09
0.21
1.0
1.1
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
11
0.00
0.21
0.0
1.0
—
282.1
—
0
11
(3038385) Creatinine [Moles/volume] in Peritoneal fluid
0
10
0.00
0.21
0.0
1.2
—
178.4
—
0
10
(43055190) Macrophages [#/area] in Urine sediment by Microscopy high power field
0
12
0.00
0.21
0.0
1.2
—
1.0
—
0
6
(40763641) Cell count and Differential panel - Peritoneal dialysis fluid
0
12
0.00
0.21
0.0
6.5
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
13
0.00
0.21
0.0
2.2
—
—
—
0
0
(3003752) BK virus DNA [Units/volume] (viral load) in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
2.8
—
—
—
0
0
(3032390) JC virus DNA [#/volume] (viral load) in Urine by NAA with probe detection
0
14
0.00
0.20
0.0
2.4
—
—
—
0
0
(3050099) BK virus DNA [#/volume] (viral load) in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
4.3
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
6
51
1.18
0.19
1.0
1.0
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
64
685
0.93
0.19
1.5
1.4
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
22
249
0.88
0.19
2.9
3.6
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
6
53
1.13
0.18
1.0
1.1
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
33
299
1.10
0.18
4.0
2.3
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
36
328
1.10
0.18
1.0
1.0
—
—
—
0
0
(40765089) Chromosome analysis panel - Blood by G-banded
15
128
1.17
0.18
1.0
1.0
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
557
5464
1.02
0.18
1.4
1.6
—
—
—
0
0
(4306422)
78
736
1.06
0.18
1.3
1.2
—
—
—
0
0
(3009550) Parvovirus B19 IgG Ab [Titer] in Serum
14
163
0.86
0.17
1.5
1.2
—
—
—
0
0
(3019250) Coagulation factor VIII activity actual/normal in Platelet poor plasma by Coagulation assay
123
1284
0.96
0.17
2.4
2.4
%
172.0
187.3
1.14
113
1223
(3033670) Parathyrin related protein [Moles/volume] in Serum or Plasma
5
67
0.75
0.17
1.0
1.1
pmol/l
—
5.6
—
0
11
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
36
330
1.09
0.16
1.0
1.0
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
82
864
0.95
0.16
1.1
1.4
u/ml
99.4
116.0
1.23
30
171
(40762119) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum
34
369
0.92
0.15
1.1
1.1
—
27.2
—
0
5
(40761535) Cells panel - Urine sediment
339
3316
1.02
0.15
3.3
3.4
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
23
207
1.11
0.15
2.7
2.3
umol/l
61.2
53.6
0.43
18
172
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
167
1724
0.97
0.14
1.9
1.8
g/l
1.7
1.5
1.16
143
1487
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
101
970
1.04
0.13
1.1
1.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
495
5028
0.98
0.13
2.3
2.8
umol/l
6.9
7.7
0.41
409
4383
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
11
94
1.17
0.13
1.0
1.1
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
70
667
1.05
0.13
1.8
1.3
u/l
23.9
41.5
1.14
63
584
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
73
699
1.04
0.11
1.3
1.4
nmol/l
0.3
0.4
0.38
55
557
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
166
1617
1.03
0.11
4.3
5.7
%
1.8
1.7
0.79
147
1508
(40768793) Breast Pathology biopsy report
91
944
0.96
0.11
1.4
1.3
—
—
—
0
0
(3034891) Synovial lining cells/100 cells in Synovial fluid
21
192
1.09
0.10
1.5
1.5
%
1.5
3.7
—
6
42
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
69
719
0.96
0.10
1.4
1.2
u/ml
5.1
4.5
0.18
26
313
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
71
739
0.96
0.10
1.2
1.1
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
901
9090
0.99
0.10
3.7
3.7
kg/l
1.0
1.0
0.99
171
1298
(3019977) pH of Arterial blood
24
222
1.08
0.10
1.5
3.3
ph
7.4
7.4
—
10
73
(3019832) Treponema pallidum Ab [Presence] in Serum
428
4338
0.99
0.10
1.6
1.7
—
—
—
0
0
(3026515) Parvovirus B19 IgM Ab [Units/volume] in Serum
18
197
0.91
0.09
1.4
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
89
920
0.97
0.09
1.3
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
76
787
0.97
0.09
1.1
1.2
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
109
1121
0.97
0.09
1.7
1.8
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
98
951
1.03
0.09
1.2
1.4
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
35
331
1.06
0.08
2.3
2.3
ml
684.3
612.7
0.52
24
225
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
47
449
1.05
0.08
1.1
1.1
u/l
57.3
60.0
0.17
25
306
(3007930) Methemoglobin/Hemoglobin.total in Blood
164
1606
1.02
0.08
4.3
5.9
%
1.0
0.9
2.37
145
1501
(40768441) Liver Pathology biopsy report
37
351
1.05
0.08
1.3
1.4
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
5
62
0.81
0.08
10.4
9.9
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
17
185
0.92
0.08
3.5
3.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
120
1229
0.98
0.08
1.2
1.1
—
—
—
0
0
(3010370) Gastrin [Moles/volume] in Serum or Plasma
7
67
1.04
0.08
1.6
1.8
pmol/l
64.8
38.0
—
7
56
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
206
2025
1.02
0.08
1.5
1.5
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
90
875
1.03
0.08
1.2
1.3
—
—
—
0
0
(42868647) JC virus Ab [Presence] in Serum or Plasma by Immunoassay
6
70
0.86
0.07
2.3
2.0
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
8
74
1.08
0.07
1.0
1.5
—
—
—
0
0
(3020891) Body temperature
155
1580
0.98
0.07
4.7
4.9
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
12
108
1.11
0.07
1.3
1.1
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
7
84
0.83
0.07
1.0
1.9
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
9
86
1.05
0.07
1.2
1.3
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
12
132
0.91
0.06
1.0
1.1
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
19
177
1.07
0.06
2.0
1.6
—
—
—
0
0
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
19
177
1.07
0.06
2.0
1.6
—
—
—
0
0
(3035880) pH of Pleural fluid
21
197
1.07
0.06
1.6
1.4
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
131
1286
1.02
0.06
2.6
3.1
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
98
1001
0.98
0.05
2.8
2.4
ug/min
119.6
116.5
0.03
53
623
(43055514) Macroprolactin [Presence] in Serum or Plasma
10
110
0.91
0.05
3.5
1.4
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
37
383
0.97
0.04
1.5
1.5
%
39.8
31.4
0.52
19
236
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
90
917
0.98
0.04
1.1
1.2
u/ml
339.9
268.5
1.07
45
584
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
21
221
0.95
0.04
1.1
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
1245
12490
1.00
0.04
3.1
3.1
e6/l
56.4
93.2
0.94
1005
9560
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
404
4067
0.99
0.04
3.1
4.2
ug/l
5.7
31.8
2.34
324
3254
(42529406) Shigella sp [Presence] in Stool by Culture
123
1246
0.99
0.03
1.2
1.2
—
—
—
0
0
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
25
260
0.96
0.03
1.3
1.1
—
—
—
0
0
(3034603) RHD gene allele [Genotype] in Blood or Tissue by Molecular genetics method Nominal
26
270
0.96
0.03
1.5
1.5
—
—
—
0
0
(21491868) Cryoglobulin [Mass/volume] in Serum
18
171
1.05
0.03
1.1
1.2
g/l
—
0.3
—
0
13
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
51
521
0.98
0.03
1.3
1.2
—
—
—
0
0
(3010375) cycloSPORINE [Mass/volume] in Blood
24
231
1.04
0.02
29.5
24.4
ug/l
110.3
113.7
0.12
18
190
(40759040) C peptide [Moles/volume] in Serum or Plasma --post meal
41
400
1.03
0.02
2.0
1.3
nmol/l
1.4
1.4
0.04
35
364
(36304419) Bacteria [Presence] in Urine
1122
11195
1.00
0.02
2.9
2.9
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
27
262
1.03
0.02
1.2
1.2
—
—
—
0
0
(3020287) Protein C actual/normal in Platelet poor plasma by Coagulation assay
72
711
1.01
0.01
1.1
1.1
%
113.9
116.1
0.31
59
653
(42869547) Procollagen type III.N-terminal propeptide [Mass/volume] in Serum
14
133
1.05
0.01
1.4
1.4
ug/l
7.6
8.5
0.56
14
133
(3026250) Tacrolimus [Mass/volume] in Blood
22
213
1.03
0.01
26.1
33.3
ug/l
7.1
7.5
0.48
15
194
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
158
1588
0.99
0.01
1.5
1.5
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
123
1237
0.99
0.00
1.2
1.1
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
220
2193
1.00
0.00
7.1
11.0
—
—
—
0
0
(3042810) Amyloid beta 42 peptide [Mass/volume] in Cerebral spinal fluid
29
285
1.02
0.00
1.0
1.0
ng/l
773.3
733.3
0.17
23
195
(3000242) Tau protein [Mass/volume] in Cerebral spinal fluid
29
285
1.02
0.00
1.0
1.0
ng/l
286.5
332.1
0.66
22
199
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
35
355
0.99
0.00
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
12
124
0.97
0.00
1.2
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
35
354
0.99
0.00
1.1
1.2
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
35
354
0.99
0.00
1.1
1.2
—
—
—
0
0
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
21
207
1.01
0.00
1.2
2.5
umol/l
51.1
155.9
—
9
115
(43055225) Phosphorylated tau 181 [Mass/volume] in Cerebral spinal fluid by Immunoassay
29
287
1.01
0.00
1.0
1.0
ng/l
42.8
46.3
0.20
21
195
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
36
357
1.01
0.00
1.1
1.2
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
36
357
1.01
0.00
1.1
1.2
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
36
357
1.01
0.00
1.1
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
103
1026
1.00
0.00
1.4
1.5
e6/l
5821.4
1322.5
0.37
90
822
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
103
1026
1.00
0.00
1.3
1.4
e6/l
55.4
25.3
0.43
87
784
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
20
201
1.00
0.00
1.1
1.0
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
8
85
0.94
0.00
2.0
2.5
—
—
—
0
0
(3029715) Chromosome analysis.interphase [Interpretation] in Bone marrow by FISH Narrative
7
72
0.97
0.00
1.0
1.3
—
—
—
0
0
(36303858) Crystals [Presence] in Urine
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
35
350
1.00
0.00
1.1
1.1
—
—
—
0
0
(3027540) Rickettsia typhi Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3002079) Sodium [Moles/time] in 24 hour Urine
0
9
0.00
0.00
0.0
1.1
—
128.4
—
0
9
(3042517) Benzodiazepines panel - Urine
5
51
0.98
0.00
1.4
2.2
—
—
—
0
0
(40769427) Triglyceride [Moles/volume] in Peritoneal fluid
0
9
0.00
0.00
0.0
1.3
—
2814.1
—
0
9
(3001218) Citrate [Mass/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.7
—
—
—
0
0
(3043722) Hyaline casts [#/area] in Urine sediment by Automated count
0
7
0.00
0.00
0.0
1.0
—
1.7
—
0
7
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
5
52
0.96
0.00
1.0
1.3
—
—
—
0
0
(3000690) Aldosterone [Moles/time] in 24 hour Urine
0
6
0.00
0.00
0.0
1.0
—
37.2
—
0
6
(3008343) Lysozyme [Mass/volume] in Urine
0
5
0.00
0.00
0.0
1.0
—
0.4
—
0
5
(3003157) Bacteria [#/volume] in Mother's milk
0
6
0.00
0.00
0.0
8.0
—
—
—
0
0
(3046682) IgA [Presence] in Skin by Immunofluorescence
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037377) Propoxyphene + Norpropoxyphene [Presence] in Urine by Confirmatory method
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3002719) Hemoglobin [Mass/volume] in Urine
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3025378) Microscopic observation [Identifier] in Cervix by Cyto stain
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3008640) Bordetella pertussis IgG Ab [Titer] in Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
6
64
0.94
0.00
1.2
1.1
—
—
—
0
0
(3023693) von Willebrand factor (vWf) multimers in Platelet poor plasma by Immunoblot
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3002619) Bacteria identified in Specimen by Culture
8
80
1.00
0.00
2.6
1.2
—
—
—
0
0
(3009992) Blasts/100 cells in Bone marrow
0
5
0.00
0.00
0.0
2.2
—
2.6
—
0
5
Mortality – FinRegistry
↥This endpoint is excluded from FinRegistry analyses (omitted endpoint).
Relationships between endpoints
↥Index endpoint: FESS – FESS (DNB20)
GWS hits: -
This endpoint is excluded from FinRegistry analyses (omitted endpoint).